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Two forms of cancer afkcting a large number of individuals are breast cancer 
and colon cancer. In 2003, it was projected that qiproximatelÿ 2100Ô Canadians would 
be diagnosed with breast cancer and anotherlSOOO would be diagnosed widi colorectal
cancer (Canadian Cancer Society 2003a, Canadian Cancer Society 2003b). Optical 
spectroscopy techniques for discerning biochemical and morphological properties have 
been investigated for potential in detecting these two types of cancer. Techniques based 
on absorption and fluorescence spectroscopy were developed and preliminary data were 
<)btairK)d uairy; caricerrms arwl normal colon tissue, and using living Actin and 111 GFP 
tagged MCF-7 breast cancer cells. Analysis of absorption spectra for normal and 
cancerous colon tissue samples revealed a shift between the two, vvhictiinay si%gest a 
potential method to distinguish between the two tissue types. Fluorescence spectroscopy 
and imaging were also performed on the colon tissue samples. Analysis of the 
spectroscopic data revealed potential methods for differentiating between tissues. 
Fluorescence measurements were performed with living Actin and HI GFP tagged 
MCF-7 breast cancer cells to investigate the value of imaging and spectroscopy under 
identical conditions. Various stages of mitosis and cellular movement were observed. 
As an extrapolation of this study some cells were irradiated with 5 Gy of Cobalt-60 
gamma rays, but no difkrences between irradiated and non-irradiated samples were 
noted. These pmliminary results reveal a potential application for optical diagnostic 
techniques, although further investigations are required.
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1. INTRODUCTION
In Canada, it is estimated that 145500 new cases of cancer will be diagnosed this 
year (Canadian Cancer Society 2004). In 2003, approximately 21000 women and men 
would have been diagnosed with breast cancer and 18000 men and women would have 
been diagnosed with colorectal cancer (Canadian Cancer Society 2003a, Canadian 
Cancer Society 2003b). As a result it is estimated that about 5300 breast cancer patients 
and 8300 colorectal cancer patients will die. To improve chances of survival, early 
detection and screening is essendal. OpGcal spectroscopy could aid in such techniques. 
Optical spectroscopy has been an active area of research for noninvasive diagnostic 
techniques because of its potential to provide biochemical and morphological properties 
of cells and tissue (Ramanujam 2000). The work presented in this thesis investigated the 
potential for optical spectroscopy techniques and instrumentation to form the basis of 
tools used to characterize normal and cancerous Gssue. In particular, a breast cancer cell 
line and colon tissues were examined. The thesis is divided into a theoretical discussion 
of techniques studied, instrumentation used for optical spectroscopy, the experiments 
carried out to characterize normal and cancerous colon tissue and breast cancer cells, the 
eBects of radiation on these cells, discussion, and conclusions.
2. THEORY
Spectroscopic techniques take advantage of the interactions of electromagnetic 
radiation or light with matter. In general, such techniques have three aspects: excitation 
from electromagnetic radiation, measurement of the light-tissue interaction, and analysis 
and interpretation of the spectra (Ramanujam 2000). Clearly for optimal applicarion of
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
optical spectroscopy it is important to have an understanding of light-Gssue interacGons, 
and the complex structure of tissue. The principles of Guorescence spectroscopy will be 
discussed, with a brief historical overview, including a descripGon of the Guorescence 
process and an introducGon to Guorophores and their key role. Fluorescence im a g in g  
for localizaGon will also be discussed with an overview of Guorescence microscopy and 
CCD cameras. Current diagnosGc techniques for breast cancer and colon cancer 
detection will be discussed to illustrate the need to investigate new techniques. Finally, 
an introducGon to radiobiology will be presented to show eGects of radiaGon on cells.
2.1. LIGHT -  TISSUE INTERACTIONS
Upon interaction with tissue, light or electromagnetic radiation can undergo various 
interactions that are highly wavelength dependent. Figure 2-1, adapted from Beiser 
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Figure 2-1. EM RadiaGon Spectrum (Beiser 1995)
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For optical spectroscopy the region of interest extends through the ultraviolet (UV), 
visible (VIS), and the near-infrared (NIR) regions making up only a small portion of the 
electromagnetic spectrum. Wilson (2002) states that the optical range is useful in giving 
biochemical information of tissue for two fundamental reasons: the molecular energy 
level difkrence in tissue corresponds to the opGcal photon energies and the size of 
macromolecuies in cells and tissues correspond to the optical wavelength range. The 
optical photon energies are on the order of 10"̂  eV to 10  ̂eV, and the optical wavelength 
range is on the order of micrometers (pm) as seen in frgure 2-1.
A typical situation of light incident on tissue with indices of refraction ni and nz 
is depicted in frgure 2-2 modifred from Niemz (1996). The light incident on tissue has 






Figure 2-2. Interactions of Light with Tissue (Niemz 1996).
2.1.1. Reflection
Reflection occurs when light incident on an interface such as a tissue surface is 
deflected without a change in the wavelength. In general, the incident angle 8 has to 
equal the reflected angle 8’ in the plane of incidence as illustrated in frgure 2-2 and 
expressed in equation 2-1.
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Equation 2-1. Law of Reflecdon.
'  Ï
There are two forms of reflection, specular and diffuse, that are highly dependent on the
surface of the interface. For specular reflection to dominate, the interface surface must
be relatively smooth so that the irregularities are small compared to the wavelength of
light allowing the reflection to occur in the plane of incidence. In comparison, diffuse
reflection occurs at rough surfaces Mtere irregulariGes are equal to or greater than the
wavelength of light In general, diffuse reflectance occurs in all tissues where the
reflected light does not necessarily lie in the plane of incidence (Niemz 1996).
Reflectance is a function of wavelength and is evaluated as a fraction of the emitted
intensity over the incident intensity as given by equation 2-2.
Equation 2-2. Reflectance.
K -
Reflectance, incident intensity, and emitted intensity are denoted by R, 1% and I 
respectively. In general, a reflection spectrum is a plot of the percent reflectance (%R) 
versus wavelength.
2 .1 2 . R e fa c tio n
When light passes from one medium to another, such as air to tissue at an 
oblique angle, the change in direction of propagation is called refraction. RefracGon can 
be explained by SnelTs Law that relates the refracGve index of the medium to the angle 
of propagaGon in that medium (PedrotG and PedrotG 1993) as expressed in equaGon 2-3.
Equation 2-3. Snell’s Law.
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0 is the angle of the incident light on the medium, and 6" is the angle of refraction in the 
medium that depends on the indices of lefracGon ni and nz of the two media. The index 
of refraction is the ratio of the speed of light in a vacuum to the speed of light in the 
medium as expressed in equation 2-4.
Equation 2-4. Index of Refraction
The speed of light (c) in a vacuum is 2.998x10® m/s, and v is the speed of light in the 
media in which it is traveling through.
2.13. Absorption
If a photon interacting with a molecule has an energy corresponding to the 
molecules electronic state energy difference, absorption can occur. Figure 2-3, is an 
electronic energy level (Jablonski) diagram illustrating the absorption process.
E n erg y
Figure 2-3. Jablonski Diagram of Absorption.
The molecule absorbs a photon of energy hvo, raising the molecule to a higher singlet 
electronic energy level (Si) from the ground energy level (So). Each electronic energy 
level contains vibrational energy levels (vo). Absorbance can be defined using the Beer- 
Lambert law stated in equation 2-5 as a function of wavelength relating the incident 
intensity to the emitted intensity:
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Equation 2-5. Beer-Lambert Law.
A is the absorbance, L, is the incident intensity, and I is the emitted intensity. The Beer- 
Lambert law is derived with the assumption that the absorbing material is homogeneous. 
The Beer-Lambert law 6 ils in k u r cases because this assumption does not hold:
different forms of absorbing molecules are in equilibrium; solute and solvents form 
association complexes; thermal equilibrium; or for the presence fluorescent compounds 
or compounds changed by irradiation (Pavia gf a/. 1996). An absorption spectrum is a 
plot of the absorbance versus the wavelength. Absorption plays a key role in several
processes including the excitation stage of fluorescence, phosphorescence, and Raman 
scattering. Absorption in tissue is caused mainly by oxyhemoglobin, melanin, 
deoxyhemoglobin, myoglobin, water, and proteins (Richards-Kortem and Sevick- 
Muraca 1996). The absorption wavelengths of the tissue components adapted from af 
Klinteberg (2000) and Wilson (2002) are summarized in table 2-1.
Table 2-1. Absorption Wavelengths of Tissue Components
Molecule Absorption
Oxyhemoglobin 418 nm, 542 nm, and 577 nm
Deoxyhemoglobin 430 nm, 450 nm, and 750 nm
Water Below 200 nm, and above 1300 nm
Proteins, Amino Acids 100 nm to 400 nm
Melanin VIS
The visible to near-infrared region of the spectrum (400 nm to 1300 nm) is primarily 
where these molecules absorb with the notable exception of proteins that absorb in the 
ultraviolet region.
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2.1.4. Scattering
Scattering processes, unlike the absorption process do not correspond to resonant 
frequencies of a molecule. Scattering can be divided into two categories: elastic and 
inelastic. Elastically scattered photons have the same energy as the incident photons but 
have a different direction. Photons scattered inelastically have a lower energy compared 
to the incident photons (af Klinteberg 2000). In general, tissues are forward scattering 
for the photon energy range of 0.56 eV to 3.55 eV (Niemz 1996, Richards-Kortum and 
Sevick-Muraca 1996).
Rayleigh scattering and Mie scattering are forms of elastic scattering. For 
Rayleigh scattering, particles must be much smaller in size relative to the incident 
wavelength; Mie scattering particles are closer to the size of the incident wavelength. 
Rayleigh scattering occurs when a molecule is moved to an excited state through 
absorption of a photon. The excited state is unstable so the molecule loses energy, 
returning to the ground state a short time later with the emission of a photon of the same 





Figure 2-4. Jablonski Diagram of Rayleigh Scatterii%.
The excited molecule relaxes to the same vibrational level as the original state (i.e. from 
Vo excited state and back to vo). Rayleigh scattering has a radial direction and has a
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wavelength dependence of Mie scattering has a forward direction and has a weaker 
dependence on wavelength  ̂ (Niemz 1996). Biological tissues have been
observed to scatter in the forward direcGon but the wavelength dependence was greater 
than Mie scattering predicted (Niemz 1996 and Richards-Kortem and Sevick-Muraca 
1996).
A form of inelasGc scattering is Raman. When an incident photon collides with a 
molecule, a change in vibrational or rotational energy (AEm) occurs resulting in Raman 
scattering (Colthup ef o/.1990). Figure 2-5, adapted from Lin-Vien gf oZ. (1991), 







Figure 2-5. Jablonski Diagram ofRaman Scattering (Lin-Vien gt oZ. 1991).
The excited molecule relaxes to an elevated vibraGonal level v% compared to the original
state Vo resulting in Stokes lines. AnG-Stokes lines result when the excited molecule
relaxes to a lower vibraGonal level compared to the original state (i.e. V] to vo). To
conserve energy the scattering photon (hv,) must differ from the incident photon (hvo)
shown in equaGon 2-6.
Equation 2-6. Change in Energy of a Molecule.
Stokes lines are present in the Raman spectra for posiGve AEm, anG-Stokes lines are 
present in the Raman spectra for negaGve AEg,. Stokes lines are red shifted relaGve to
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the excitation energy \riiereas anG-Stokes lines are bine shifted. The change in energy 
between the incident and scattered photon is unique to molecular vibraGon and can be
used to determine chemical structure. A Raman signal is approximately 10'̂  times 
weaker than a fluorescence signal, so, as a result, imaging is not pracGcable (Wilson 
2002).
AbsorpGon and elasGc scattering techniques have been used as diagnosGc tools 
for ophthalmology and white Gght endoscopy (Wilson 2002). Raman qiectroscopy has 
been used k r  disease detecGon and Gssue characterizaGon (Hanlon gf uZ. 2000 and 
Wilson 2002). Current diagnosGc and therapeuGc applicaGons tend to operate in the 600
nm to 1000 nm region where tissue absorption is low compared to tissue scattering, a 




The fluorescence phenomenon has been documented in Chinese literature as far 
back as the 1500’s (Shannon Luminous Materials, Inc. 2001). Centuries later, in 1852, 
Sir George Skkes observed that the energy of fluorescence emission is lower than the 
energy of excitaGon. This observaGon led k  the krmulaGon of Stokes law and the 
introducGon of the term fluorescence. Lakowicz (1999) states Skkes law as 
fluorescence occurring at longer wavelengths than the excited light Policard flrst 
invesGgated fluorescence spectroscopy k r  cancer detecGon in 1924 using a UV/VIS 
(ultra-violet and visible) Gght source k r  the detecGon of aukfluorescence of porphyrins 
(Wagnières gZ oZ. 1998). Over the past 20 years, fluorescence spectroscopy has been
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further investigated as a potential diagnostic technique. The research group headed by 
Robert Alfano has pioneered these investigations (Alfano ez oZ. 1984, Alfano gz oZ. 1987, 
Lui gZ oZ. 1992, Katz and Alfano 1996, Zhandin gZ oZ. 1997, and Gayen and Alfano 
1999). Remadcable progress has been made with fluorescence spectroscopy for medical 
gqiplications including cancer detecGon (Yang gZ oZ. 1997).
2.22. Flmorescemce Theory
Fluorescence is a three-stage process where a photon from an external excitation 
source is absorbed by a fluorescent molecule, resulting in a subsequent spontaneous 
emission by the molecule of a longer wavelength photon. Lakowicz (1999), Ramanujam 
(2000), and Molecular Probes, Inc. (2002) describe the three-stage fluorescence process 
as excitation, excited lifeGme, and fluorescence emission. As already described 
excitation occurs when a molecule absorbs a photon of a given energy hvo from an 
external light source causing the molecule to excite to a higher energy level (Sz). The 
light absoipGon occurs almost immediately (roughly 10'̂  ̂seconds). During the excited 
lifeGme the fluorescent molecule is subject to various interacGons. Partial energy 
dissipaGon by means of internal conversion occurs with a rapid relaxaGon of 10'̂  ̂
seconds or less from a higher vibraGonal level (v,) of Sz or Si to vo of Si (Lakowicz 
1999). Once excited, molecules can return to the ground state through non-radiaGve or 
radiaGve processes. Fluorescence emission is the radiaGve process ^riiere the ground 
state is achieved through the emission of a photon of energy hv corresponding to the 
energy difference between So and Si. The emitted photon has a lower energy than the 
excitaGon photon due to energy dissipaGon such as internal conversion, a non-radiaGve
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Figure 2-6. Jablonski Diagram of Fluorescence (Molecular Probes, Inc. 2002). 
Singlet electronic energy levels have electron spin quantum numbers with a sum 
of zero therefore the electron in the excited orbital has an opposite spin orientation 
relative to the ground state electron (Lakowicz 1999). In goieral, the ground states of
most molecules, with the notable exception of the oxygen molecule (O2), have singlet 
ground states (So). The energy level differences between two energy levels is roughly 
6.21 eV to 1.24 eV, corresponds to light with wavelength within the range of 200 nm to 
1000 nm.
Fluorescent molecules are characterized by their quantum yield (<p) and lifetime 
(r) (Ramanujam 2000). Quantum yield represents the efficiency with which a 
fluorescent molecule ctmverts abKxxrbedlig^üto enntted lÿght and, as shown in equation 
2-7, is the ratio of the number of photons emitted to the number absorbed.
Equation 2-7. Quantum Yield of Fluorescence.
- k
In this equation, Ngmis the number of photons emitted and N *is the number of photons 
absKMrbeKl in tlw; sample and p is  the (pianOum yield, TTbe cpiarduni yield rarigesfrcnil) far 
non-flimrescent molecules to 1 for fluorescent molecules widi 100% efBciency. Due to
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Stokes losses, the quantum yield of fluorescence is always less than 1. The higher the 
quantum yield for fluorescent molecules the better they can be observed. Fluorescence 
lifetime (?) is the average time the fluorescent molecules spends in the excited state 
before returning to the ground state (Lakowicz 1999). Flimrescent molecules have 
lifetimes on the order of 10"̂  seconds.
Data frcMii fluorescence spectroscopy can be analyzed as excitation spectra or
emission spectra. In a fluorescence excitation spectrum the emission wavelength is 
fixed and the fluorescence intensities are plotted over a range of excitation wavelengths. 
A fluorescence emission spectrum is a plot of the fluorescence intensities over a range of
emission wavelengths for a fixed excitation wavelength (Gillenwater 1998). In general, 
excitation spectra are similar to corresponding absorption spectra, showing the relative 
emission of the fluorescent molecules at each excitation wavelength (Lakowicz 1999). 
Emission spectra show the photon emission rate at each wavelength and are highly 
dependent on the chemical structure of fluorescent molecules present.
2.23. Flaorophores
Certain molecules known as fluorophores have daeabiUqftofhMMeace at a longer 
wavelength than the excited light There are two classiGcations of Guorophores: 
exogenous or endogenous. Exogenous Guorophores need to be introduced into a sample 
while endogenous Guorophores are naturaGy occurring in a sample. Fluorescence 
spectroscopy techniques using Guorophores have been investigated for molecular 
biology and medical ^plicaGons. In particular, exogenous Guorophores such as 6- 
aminolevulinic acid (5-ALA), induced protoporphyrin DC (PpDC), and hematoporphyrin 
derivative (HpD) have been studied as photosensiGve agents in photodynamic therapy
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(PDT) (Ramanujam 2000 and Wagnières ef a/. 1998). Green fluorescent protein (GFP) 
is important in biological research for in fifw investigations of distribution and 
interaction of cell and tissue components. Green fluorescence protein originates 6om 
JellyGsh yfggworgn Ffctonn (Knight and Billinton 2001). Ethidium Bromide (EtBr) is 
another exogenous Quorophore commonly used to stain nucleic acid. Figure 2-7, 6om 




Figure 2-7. Molecular Structure of EtBr (Molecular Probes 2003).
EtBr alone has an absorption (or excitation) peak near 480 nm and an emission peak 
maximum near 620 nm. Upon binding to DNA the excitation peak shifts to 530 nm and 
the emission peak to 600 nm (Sigma-Aldrich Co. 2003). Endogenous fluorophores have 
been studied as potential diagnostic tools through attempts to use them to diSerentiate 
normal and diseased tissues such as breast, colon, lung, brain, stomach and cervical 
tissue. Biological tissues are comprised of a complex combination of molecules such as 
endogenous absorbers and endogenous fluorophores. Table 2-2 ftom Ramanujam 
(2000) summarized endogenous fluorophores ft)und in tissue including the wavelengths 
correqx)nding to the peak maxima for the excitation and fluorescence emission.
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,-2. Biological Endogenous Fluorophores (Ramanujam 2(
Endogenous Excitation Emission






















Pyridoxic Acid 315 425
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The excitation wavelengths of these fluorophores range ftom approximately 260 nm to 
450 nm and a fluorescence emission wavelength range ftom approximately 280 nm to 
700 nm. Aromatic amino acids, structural proteins, enzymes and coenzymes are some 
of the endogenous fluorophores that are believed to play significant roles in normal 
tissues and cancerous tissues.
Amino acids are the basic building block of proteins. Tryptophan, tyrosine, and 
phenylalanine are amino acids with aromatic side chains that fluoresce. Figure 2-8 
modified ftom Alberts ef a/. (2002) depicts the chemical structures of these three amino 
acids.
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Figure 2-8. Aromatic Amino Acids; (a) tryptophan, (b) tyrosine,
(c) phenylalanine (Alberts et al. 2002).
The excitation &)r these amino acids occurs in the 260 nm to 280 nm range with the 
emission in the 280 nm to 350 nm range. Tryptophan has a broader fluorescence 
emission range while the range for phenylalanine is narrower. The quantum yield and 
fluorescence lifetime of the three amino acids are given in table 2-3.
Table 2-3. Quantum Yield and Lifetimes for Aromatic Amino Acids (Lakowicz 1999).





Tryptophan and tyrosine have similar quantum yields, while phenylalanine has a much 
lower quantum yield. Tryptophan is more dominant, with higher fluorescence intensities 
than tyrosine and phenylalanine. Fluorescence intensity in this context refers to the 
number of emitted photons of a given energy per unit area. The fluorescence intensity is 
dependent on the absorption, concentration, quantum yield, excitation source and the 
efhciency of the instrumentation. Phenylalanine has the lowest fluorescence intensity 
due to the low quantum yield; its fluorescence emission is rarely observed (Lakowicz 
1999).
Ganesan er a/. (1998) investigated the fluorescence emission spectra for normal 
and malignant human oral epithelial cells at an emission of 340 nm. These spectra
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showed diftorences that were attributed to tryptophan, tyrosine, and phenylalanine. The 
normalized fluorescence excitation spectra were greater for normal cells in the 250 nm 
to 290 nm range and greater for the malignant cells in the 290 nm to 320 nm range. The 
peak near 290 nm for the malignant cells was red shifted relative to the normal cells.
Structural proteins such as collagen and elastin are in^or components in the 
extracellular matrix. Collagen is comprised of ftbrous proteins that give connective 
tissue its tensile strength. Elastin is loose and unstructured covalently linked netting 
giving skin and other tissue elastic properties (Alberts gf o/. 2002). Figure 2-9 ftom 
Alberts et oZ. (2002) illustrates (A) collagen and (B) elastin.
etostic fiber
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Figure 2-9. Structural Proteins (Alberts et aZ. 2002).
Structural proteins are common components in skin and bone. From table 2-2, the 
excitation maximum for collagen is 325 nm and for elastin are 290 nm and 325 nm. 
These structural proteins have an emission maxima range ftom 340 nm to 405 nm.
Nicotinamide adenine dinucleotide (NADH) and flavins play an important role in 
cellular energy metabolism. NADH in the reduced form and flavins in the oxidized 
form in ftgure 2-10 are electron carriers.
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Figure 2-10. NADH and Flavin (Alberts et al. 2002).
The reduced nicotinamide ring of NADH and the oxidized form of FAD can fluoresce at 
wavelengths of approximately 440 nm and 535 nm req>ectively.
Main peaks near 520 nm to 530 nm in the fluorescence spectra for normal and 
malignant breast tissues at 488 nm, 514.4 nm, and 457.9 nm excitations with an argon 
ion laser have been attributed to flavins (FAD). In this study the spectra of malignant 
tissue had a smoother profile and a greater intensity in the wavelength range of 460 nm 
to 700 nm compared to the spectra of normal breast tissue (Alfano ef a/. 1987 and 
A16no gf a/. 1989).
Fluorescence spectroscopy of breast tissue has shown difkrences in normal and 
cancerous tissues that have been attributed to structmal proteins, NADH, and flavins 
(Mfgumber ef a/. 1996, Gupta gf ul. 1997, Jain gf ul. 1998, and umber gf u7. 1999). 
Jain gf o/. (1998) found that for 310 nm excitation the fluorescence spectra of malignant 
1%east tissue were approximately 2.8 times higher in intensity than the normal breast 
tissue in the 325 nm to 575 nm range. Results suggest that the concentration of collagen, 
elastin, NADH, and flavins are greater in cancerous tissue than in normal tissue. 
Mfyumber gf a/. (1999) found that at 337 nm excitation the fluorescence emission
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spectra of cancerous breast tissue were higher in intensity compared to normal or benign 
breast tissue. Further investigations using fluorescence excitation spectra determined 
that NADH has a higher concentration in cancerous tissues.
Liu et u/. (1992) investigated fluorescence spectroscopy of breast tissue and 
breast cells with excitation at 300 nm and 353 nm respectively. The ratio of the 
emissions at 340 nm to those at 440 nm was calculated for the normal, benign, and 
cancerous breast tissue. The ratio for the cancerous tissue was significantly greater 
compared to the normal and benign. The difkrences were likely due to the 
concentration of tryptophan, tyrosine, NADH, and the structural proteins. Fluorescence 
measurements of cultured cells were investigated to provide more insight into tissue 
fluorescence. As a result the cancerous cell lines had a relatively stronger emission from 
NADH relative to that of normal tissue. The ratio of the emissions at 450 nm to those at 
525 nm was greater for the cancerous cell lines compared to the normal cell line.
Fluorescence spectroscopy of colon tissue has shown difkrences in normal and 
malignant tissues that have been attributed to collagen, NADH, and flavins (Schomacker 
1992a, and Schomacker 1992b). With ultraviolet excitation, the fluorescence spectra 
changed signiGcantly between normal and malignant colon tissue. Using a multivariable 
linear regression analysis, the intensity of normal colon tissue was greater than 
malignant tissue at a wavelength of 390 nm. Mrgor bands attributed to emission ûom 
fluorophores were centered at 390 nm and 460 nm, with minor bands at 630 nm to 680 
run.
Huang ef o/. (1998) studied fluorescence q>ectroscopy of normal and cancerous 
colon tissue using wavelengths 6om a continuous wave mixed-gas (Ar/Kr) laser. The 
fluorescence emission spectra in the 520 nm to 620 nm range were similar far both
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
19
normal and cancerous. Peaks in the 635 nm, 675 nm, and 703 nm range were observed 
in the cancerous colon tissue and can be attributed to porphyrins.
As shown in various studies, differences in fluorescence emission spectra of 
normal, benign, and cancerous tissues can be attributed to endogenous fluorophores. 
There&re fluorescence spectroscopy has the potential to be a usehil tool in 
difkrentiating biochemical and morphological changes in tissues. Although significant 




In general, microscopy has been used primarily for investigations in biological 
and biomedical fields. Fluorescence microscopy was first developed in the early 1900’s 
with excitation of samples using transmitted light. A significant improvement to the 
fluorescence microscope was realized in 1929 Wien reflected illumination was 
introduced for sample excitation. The use of reflected light to illuminate a sample is 
referred to as epi-fluorescence. In order to retain the images observed through the 
microscope, imaging capabilities needed to be combined with the system. Initially 
imaging was achieved with photographic techniques that subsequently led to 
replacement with digital imaging detectors such as charged-coupled devices (Wang and 
Herman 1996). Although charged-coigiled devices (CCDs) were not commercially 
available until the mid 1980's for imaging applications (Mason 1999), they were first 
invented in 1970 at Bell Laboratories by Willard Boyle and George Smith (Taylor 
1998).
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23.2. Epi-fluorescence Microscopy
A fluorescence microscope is designed to deliver light to excite the sample and 
then to separate the emitted light 6om this excitation light (Herman 2001). Key 
components of a typical epi-fluorescence microscope are shown schematically in Ggure 
2-11. Excitation light passes ûom the light source, consisting of the lamp and collector 
lens, through an excitation hlter where it is reflected onto an objective to the sample by a 
dichroic beam splitter. The emitted light from the sample is transmitted back through 
the objective, passing through the beam splitter and an emission frlter to the eyepiece or 
detector. The fluorescence frlter cube is comprised of an excitation frlter, dichroic 
beam-splitter, and emission filter (re. Figure 2-12). The excitation light is of a shorter 











Figure 2-11. Schematic of an Epi-fluorescence Microscope (Reichman 2000).
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The light source required in epi-fluorescence microscopy is selected to excite the 
sample at specific wavelengths, the particular wavelengths depending on the types of 
fluorophores present in a sample. Halogen, mercury and xenon high pressure arc lamps 
are a few of the common light sources used. Halogen and xenon lamps have roughly a 
continuous emission over a broad wavelength range (UV/VIS/NIR). Mercury arc lamps 
produce line spectra with strong emission peaks at specific wavelengths (i.e. 366 nm, 
405 nm, 436 nm, 546 nm, and 578 nm).
The filter cube, as illustrated in figure 2-12, is the primary filter element in the 
epi-fluorescence microscope and is comprised of three main elements: an excitation 
filter, a dichroic beam splitter, and an emission (or barrier) filter. The excitation filter is 
a wide band pass filter that transmits a certain wavelength range of incident light. The 
coated dichroic beam splitter is aligned at an angle of 45 degrees to separate the 
excitation and emission light by 90 degrees. The coating on the beam splitter is 
designed to selectively reflect the excitation wavelengths filtered by the excitation filter 
and transmits the emitted fluorescence (Reichman 2000). The emission (or barrier) filter 
is a long pass filter that attenuates the excitation light and transmits longer wavelengths 









Figure 2-12. Filter Cube (Reichman 2000).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
22
In an epi-flnorescence microscope the objective is used to fbcns and collect light. 
Excitation light is reflected into the back aperture of the objective and focused onto the 
sample. The emitted light is also collected using the objective (Herman 2001). The 
amount of light focused on or collected from the sample depends on the numerical 
aperture and magnification of the objective. Numerical aperture (NA) as given in 
equation 2-8 (Herman 2001) is defined as the light gathering efBciency of the objective 
lens and provides a measure of detail resolution at a fixed object distance.
Equation 2-8. Numerical Aperture.
n is the refractive index (re. Equation 2-4) of medium lying between the objective and 
the sample, and a is the half cone angle of the emitted light relative to the incident light. 
The larger the numerical aperture value, the greater the brightness of the image. The 
magnification of the objective is also related to the numerical aperture, resulting in a 
trade-off situation where, when magnification is increased, image brightness decreases. 
2 3 3 . CCD Camera
Charged coupled devices (CCDs) are based on physical principles similar to 
metal oxide semiconductors (MOS). Charged coupled devices are manufactured using a 
silicon substrate (Mason 1999). In general, CCDs are comprised of light sensitive cells 
(called pixels) where the charge is generated as a result of the photoelectric effect in the 
energy range of 1.1 eV to 4.1 eV (Buil 1991 and Mason 1999). Pixels are typically 
arranged in linear or area (two-dimensional) arrays. Pixel binning represents the area of 
a single charge of all individual pixels. A pixel binning of one (1 pixel x 1 pixel) refers 
to an individual pixel, whereas a pixel binning of 2 (2 pixels x 2 pixels) refers to an area 
of four acjacent pixels which increases the sensitivity by four but decreases the
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resolution by half, As for fluorescence, the quantum efficiency for the CCD camera is 
also important relating the number of electrons collected by a given pixel to the number 
of photons incident on that pixel.
Typical charged coupled devices are built on p-type silicon with an n-type 
substrate layer on the sur6ce upon which a silicon dioxide (SiOz) layer is deposited and 
metal electrodes attached. Figure 2-13 shows a schematic of a CCD pixel (Taylor 
1998). Reverse biasing the p-n junction by applying a positive voltage (V,) to the 
electrode creates potential wells in the n-type substrate below the electrode. Photons 
with energies greater than 1 eV penetrating the silicon have sufficient energy to break 
covalent bonds, generating electron - hole pairs in the depletion region. Due to the 
electric field arising from the applied voltage (Va), the electrons migrate towards the 
SiOz layer, and become trapped in the potential wells.
Oxide î ygr
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Figure 2-13. CCD Pixel.
The number of electrons is proportional to the number of incident photons (Buil 1991 
and Taylor 1998). The electrical charge is trans&rred across the array surface to read­
out registers through charge transfer. The transfer of charge within the detector can be
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done through a number of techniques including: fr)ur-phase, three-phase, two-phase, or 
one-phase. Three-phase trans&r is a common technique vhere each pixel has three 
distinct areas (or phases) arranged vertically. During the exposure time phases 1 and 2 
collect and hold charge %hile phase 3 blocks charge. After the exposure the charge from 
phase 1 is transferred into phase 2 while phase 3 continues to block charge. Once all the 
charge from phase 1 is transferred into phase 2, phase 1 begins to blocks charge. Next, 
phase 3 collects and holds charge from phase 2 dispersing evenly through out the two 
phases (2 and 3), while phase 1 continues to block charge. The charge is then forced 
into phase 3 by blocking charge to phase 2. This process is repeated until the charge 
moves to the adjacent pixel, and completed once reaching the read-out register (Taylor 
1998 and Mason 1999). The electrical charge in the read-out registers are converted into 
a digital signal by an A/D converter.
There are four different architectural types of two-dimensional (area) array 
CCDs: full frame, frame transfer, split frame transfer, and interline transfer. They differ 
in the way in i^ c h  the light sensitive regions and read-out registers are oriented.
2.4. TISSUE DIAGNOSTICS
Optical spectroscopy has been investigated for its potential as a diagnostic tool 
far many types of tissue includii% brain (Lin ef of. 2001), breast (Pradhan et of. 2000), 
lung (Hung et a/. 1991), upper and lower gastrointestinal tract (Mayinger et a/. 2000 and 
Prosst and Gahlen 2002), and gynecological (Classman et a/. 1994). A brief discussion 
of breast and colon tissue and current diagnostic techniques will be discussed. Breast 
and colon were chosen due to available resources, and the prevalence of these types of 
cancers.
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2.4.1. Breast Tissue
The breast covers an area above the chest wall extending from the armpit to the 
sternum and up to the collarbone (Canadian Cancer Society 2002a). The female breast 
is more developed than the male breast. The main function of the breast in women is to 
produce and secrete milk to nourish newborns. Breast tissue is composed of many 
structures that can be divided into two categories: glandular and adipose. The glandular 
tissue includes lobes, lobules, and ducts. Adipose tissue is mainly fat. Figure 2-14 







Figure 2-14. Structure of the Breast (National Cancer Institute 2003).
There are about 20 lobes in a breast which are distributed about the nipple in a radial 
Ashion. The lobes consist of lobules (or milk glands) with secreting cells embedded in 
connective tissue. The milk that is produced in the lobules is carried out to the nipple 
through ducts. Adipose (fatty) tissue surrounds the lobules and ducts for protection. 
Lymph nodes act as a defense system and are located in the armpit, collarbone, and
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sternum regions filtering blood and removing impurities. Ligaments have an elastic 
property and act to support and shrqie the breast. Breast cancers are almost all 
adenocarcinomas derived from glandular epithelial tissue of the breast. (Canadian 
Cancer Society 2002a, National Cancer Institute 2003). The subtypes of breast cancer 
are generally classified by the site of origin. Ductal carcinomas originate in the ducts 
and are the most common type of breast cancer.
2i43. Breast Cancer Screening and Early Detection
It is estimated that one in nine women will develop breast cancer in their lifetime 
(Canadian Cancer Society 2003a). Canadian Cancer Society (2003a) and Tiemey et al. 
(2003) state that the common diagnostic techniques used for breast cancer detection are 
clinical breast examinations (CBE), breast-self examinations (BSE), and mammography. 
The aim of screening mammography is to detect malignant tumours in the breast at an 
early stage when no signs or symptoms are apparent (Paquette et al. 2000). About 40% 
of early breast cancers can be detected by palpation alone and 35 %-50% can be detected 
by mammography alone (Tiemey et a/. 2003). Currently clinical breast and breast-self 
examinations and mammography together are the most reliable screening tools available 
for early detectioiL
Both clinical breast examinations and breast-self examinations use palpation of 
the breast to detect changes such as lumps. Clinical breast examinations are conducted 
by a doctor or trained health pro&ssional during regularly scheduled physical 
examinations, whereas monthly BSE can be done on one's own breast.
Mammography uses low-dose x-rays of less than 0.4 cGy per view to the mid 
breast (Tiemey et a/. 2003). The image is produced as a result of x-rays being
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attenuated through absorption while they pass through the breast to the image receptor 
(usually film). The benefits of mammography include the ability to detect small 
tumours, and an increased detection of ductal carcinoma m aim (DCIS) for A^ch it is 
the only provai reliable method far detection (RadiobiologyInfi) 2002). Interpretation 
of mammograms can be difficult due to variability of the structure and density of the 
breast tissue. With age, the breast tissue composition changes fiom mostly glandular to 
mostly adipose tissue (Canadian Cancer Society 2002a). A mammogram fiom a 
younger vyoman with very dense breast tissue may not reveal the presence of a clinical 
cancer. As with other detection techniques; mammogr^hy can result in false-positives 
(findings that may turn out to be non-cancerous), or false-negatives (be missed).
Other techniques used for breast cancer detection include thermography, and 
ultrasound (Basset and Gold 1982). The working principle of thermography is detecting 
temperature variation due to metabolic changes by collecting the infrared radiation that 
is emitted. An increase in temperature results fiom the increase metabolism in tumour. 
Ultrasound uses high frequency sound waves (greater than 20000 Hz), detecting acoustic 
impedance changes between tissues.
Optical spectroscopy and imaging modalities are emerging in the diagnostic field 
as promising techniques (Gayen and Alfano 1999, and Chaudhury ef a/. 2001). Optical 
spectroscopy techniques avoid the use of ionizing radiation, which is cancer inducing, 
wdiile providing high spatial resolution that could potentially detect small tumours that 
are undetectable by pathology (Bigio and Mourant 1997 and Katz ef a/. 1996).
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2.43. Colon Tissue
The colon is part of the large intestine spanning between the small intestine and 
the rectum. The basic structure of the lower gastrointestinal tract, including the 
stomach, small intestine, colon, and rectum is shown in figure 2-15 adapted fiom 
National Cancer Institute (2002). The gastrointestinal tract forms part of the digestive 
tract, functioning to remove nutrients fiom fix)d and move waste through the body. The 










Figure 2-15. Structure of Gastrointestinal Tract 
(National Cancer Institute 2002).
The colon has fi)ur sections starting with the ascending colon, extending between the
cecum upwards to the transverse colon. The ascending colon extends upward fium the
cecum, bends and crosses the abdominal cavity to form the transverse colon. The
transverse colon leads to the descending colon and onto the sigmoid colon that curves to
a mid-plane connection to the rectum. The colon is composed of many difkrent tissue
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types enclosed in four layers. The four layers include the mucous membrane, 
submucosa, muscular layer, and serous layer. The mucous membrane has an inner 
lining (epithelium), connective tissue, and muscle; the submucosa contains connective 
tissue, glands, blood vessels, lymphatic vessels and nerves; the muscular layer contains 
connective tissue and muscle; and the serous layer is an outer lining of epithelium and 
connective tissue. Many of the colon cancers begin in the glandular cells lining the 
inside layer (mucosa membrane) of the colon (Canadian Cancer Society 2002b). Polyps 
are clusters of cells that grow, divide, and reproduce abnormally on the lining of the 
colon. Aldiough not all polyps become cancerous, most colon cancers originate with 
development of benign polyps. Approximately ninety-five percent of all colorectal 
cancers are adenocarcinomas (Holowaty et al. 1998).
2.4.4. Colon Cancer Screening and Early Detection
In Canada, colorectal cancer is the second leading cause of cancer deaths, after 
lung cancer (Holowaty ef a/. 1998). Statistics firom the Canadian Cancer Society 
estimate that one in sixteen women and one in fifteen men will develop colon cancer in 
their lifetime (Canadian Cancer Society 2003b). Fecal occult blood test (FOBT), 
colonoscopy, sigmoidoscopy, and double contrast barium enema are common diagnostic 
techniques available for colorectal cancer detection. The benefits of early detection and 
screening for colorectal cancer is currently controversial; however, the FOBT is 
endorsed by Cancer Care Ontario, the National Committee on Colorectal Cancer 
Screening, the Canadian Task Force on Preventive Health Care, Quebec and the 
National Health Technology Assessment Agencies, and the Canadian Cancer Society for 
colorectal cancer screening (Schabas 2003).
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The fecal occult blood test (FOBT) is used to detect traces of blood in the stool 
that may result fiom pre-cancerous polyps (National Cancer Institute 2002). The FOBT 
procedure can be conducted at home or in a doctor’s office and consists of acquiring 
three small stool samples onto chemically treated test strips. The test strips containing 
the samples are then analyzed at a laboratory. If traces of blood arc detected (positive 
result), further diagnostic techniques are employed to determine the cause. The benefits 
of FOBT are that it is easy, noninvasive, and cost-effective. Although shown to be 
efkctive in the prevention of cancer, it is not an ideal screening tool since almost the 
same amount of cancers are missed as detected (Schabas 2003).
Both colonoscopy and sigmoidoscopy use a white light instrument to view the 
colon and rectum, and both require that the bowels are empty and pumped with air to 
improve the imaging of the organs. Colonoscopy also typically requires that the patient 
be sedated. A long flexible tubular instrument attached to a camera is used in a 
colonoscopy to view the entire length of the colon and rectum. A sigmoidoscope is 
similar but extends only long enough to view the rectum and sigmoid (lower) colon. 
The principle benefit of these techniques is that biopsy samples of suspicious areas can 
be targeted and acquired while disadvantages include the duration, invasiveness, and 
discomfort of the procedures (Screening for Colon Cancer. 2003).
Double contrast barium enema (DCBE) and computer tom ogr^hy (CT) with 
DCBE are both x-ray imaging procedures used to provide details of the colon and 
rectum. The barium outlines the colon and rectal line so that abnormalities can be more 
readily identified. Typically several x-ray images are obtained in a given study. The 
advantage of the CT with DCBE is that a 3-dimensional image is obtained.
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2.5. RADIOBIOLOGY
Radiobiology is defined as the study of ionizing radiation interactions with 
biological systems such as biological molecules, cell components, cells, tissues, organs, 
and whole bodies (Hall 1988). Radiobiological oqieriments were not conducted until 
die late 1800's after the production of x-rays by Wilhelm Roentgen in 1895, the 
discovery of radioactivity by Antoine Henri Becquerel in 1896, and the isolation of 
rhdium by Pierre and Marie Curie in 1898 (Badash 2003 and Hall 1988).
The energy fimn the radiation can be absorbed in a volume of a biological 
system resulting in an ionization or excitation. Ionizing radiation with energies on the 
order of 4 to 25 eV are needed to excite and eject orbital electrons from atoms or 
molecules (Attix 1986 and Hall 1988). Ionizing radiation can be divided into two 
categories: charged and uncharged. Uncharged ionizing radiation includes x-rays, y- 
rays, and neutrons, and charged ionizing radiation includes electrons, protons, a- 
particles, negative m-mesons and heavy charged particles. Further discussion of ionizing 
radiation will focus primarily on x-rays and y-rays wiiich are classified as indirectly 
ionizing radiation along with neutrons.
As illustrated in the EM radiation spectrum in figure 2-1, y-rays and x-rays are 
electrom^netic radiation with energies on the order of 10  ̂eV to 10̂  eV which, for the 
most part, is significantly higher than far photons in the optical range.
X-rays and y-rays have the same nature and properties but differ in the way they 
are produced (Attix 1986 and Hall 1988). Gamma-rays are emitted fiom excited and 
unstable nuclei \^ereas x-rays originate fiom energy transitions of electrons in atoms or 
by accelerating or decelerating charged particles. For example, in x-ray tubes, electrons
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are accelerated to high energies and then decelerate wdien striking a target such as 
tungsten or gold. The deceleration results in an emission of x-ray (bremstrahlung 
radiation). In radiotherapy, y-rays, x-rays and electrons are commonly used to deliver 
treatments to cancer patients, y -rays are produced by Cobalt-60 (^Co) for external 
beam therapy and radioactive isotopes Cesium-137, IiTidium-198, and Iodine-125 (̂ ^^Cs, 
and ^^I) for brachytherapy; X-rays are typically generated with linear accelerators 
for external beam thenqry.
Indirect ionization is a two-stage process. First, as the radiation is absorbed in the 
biological material its energy is transferred to charged particles (e.g. electrons), an 
exchange that takes place on the order of 10"̂  seconds. In turn, the charged particles 
then deliver the energy along their path of travel through coloumb interactions, resulting 
in chemical or biological damage (Attix 1986 and Hall 1988). The indirectly ionizing 
radiation can interact with matter through three major processes: photoelectric, 
Compton, and pair-productiorL Which process is used is dependent iqron the energy of 
the radiation and the chemical composition of the biological material. For typical 
radiation ther^y  energies within the range of 100 keV to 30 MeV, the Compton process 
dominates. The Compton process occurs when an incident photon of a given energy hv 
collides with an unbound or loosely bound electron as in figure 2-16 (Hall 1988).
E y  h, 
mom." hy/c
0*
Figure 2-16. Compton Interaction (Hall 1988).
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The collision imparts some of incident photon's energy to the 6ee electron. As a result, 
the electron is set in motion (momentum p and energy T) at some angle 8 and the photon 
with a lower energy (hv) is scattered at some angle
Biological changes 6om x and y-rays can be caused by direct action or indirect 










Figure 2-17. Direct and Indirect Action (Attix 1986).
With direct action, the 8-rays, or secondary electrons arising 6om photon absorption 
interact directly with the DNA. The process is referred to as indirect action when a 8-ray 
interacts with a molecule such as water and produces a 6ee radical that subsequently 
interacts with the DNA to cause damage. Damage is inflicted by either single or double 
strand breaks to the sugar phosphate backbone. Indirect action is primarily responsible
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for approximately two thirds of biological dam%e (Hall 1988). Chemical chaises such 
as breakage of bonds or biological damage in cells may not be evident until attempts are 
made by the cell to divide. The cell can either efkct repair (i.e. only a single strand 
break of the DNA) or lose its reproductive integrity (cell death). Cellular death may not 
be evident during the 5rst division but may occur after several divisions. The phase of 
the cell cycle when radiation exposure occurs also plays a signiGcant role in the extent 
of the biological damage. The cells are most sensitive during the 02 phase when the 
DNA have been replicated and the M phase when the nuclei divide (mitosis) and cells 
split (cytokinesis). The G1 phase, the interval between M and S, and the S phase when 
the DNA are replicating are the least sensitive. In general, chemical and biological 
damage may take days, years, or even generations to manifest. For example, mutations 
to the DNA as a result of radiation exposure may be suppressed for several generations 
before being expressed.
3. INSTRUMENTATION
The basic components necessary for optical spectroscopic measurements include 
a light source, illumination and collection optics, and a computer controlled 
spectrometer. A spectroscopic measurement system is used for absorption, \^ereas a 
combined spectroscopic measurement and imaging system is used 6)r fluorescence.
3.1. ABSORPTION SPECTROSCOPY
Absorption spectroscopy was investigated using a measurement system that 
samples a tissue area of igyproximately 1.6 cm^. A '̂ point" measurement system as 
deGned by Wagnières et a/. (1998) is one that samples a tissue area typically having a
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diameter range of 50 pm to 1000 pm. So our system used for absorption spectroscopy 
can not be considered a point measurement system. A typical system &om Ocean 
Optics, Inc. (2000a) shown schematically in figure 3-1, is a computer controlled 
spectrometer connected to a light source, flexible illumination and collection Sbres, and 
a sample holder. The instrumentation used to perform absorption spectroscopy 









Figure 3-1. Basic Components for Absorption Spectroscopy 
(Ocean Optics, Inc. 2000a).
Mr
Figure 3-2. Components for Absorption Spectroscopy.
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3.1.1. Light Source
The excitation lyght source used for the absorption measurements is a tungsten 
halogen light source (LS-1) with a wavelength range of 360 nm to 2000 nm and a power 
ou^nit of 6.5 W (Ocean Optics, Inc. 2000b). The light source has an associated color 
temperature of 3100 K. The white light source loffers a built in Glter slot to 
accommodate attenuation or colour Glters iq) to 3mm thick allowing for a measure of 
tuning of the excitation wavelength. A collimating lens (74-VIS) is attached to the light 
source to coiq)le the light into an optical fibre for illumination. The 74-VIS collimating 
lens accommodates a spectral wavelength range of 350 nm to 2000 nm and is composed 
ofborosilicate crown (BK-7) glass.
3.1.2. Illumination a n d  Collection
The incident light is guided through a 400 pm diameter fibre optic patch cord 
and focused onto the sample by a collimating lens (74-UV). The collimating lens and 
the sample are separated by approximately 6 cm. Subsequent to interaction with the 
tissue, the light is recollected by a second collimating lens (74-UV) attached to a 400 pm 
diameter fibre optic patch cord tliat directs light into the spectrometer. The 74-UV 
collimating lerwses transmit a spectral waveleigih range of 200 nm to 2000 nm and are 
composed of fused silica. The 400 pm diameter patch cords, also composed of silica, 
are single süismdkxi with a rmmericwil aperture (NA) of 0.22. Their optimal transmission 
wavelengths range 6om 200 nm to 750 nm, but good 6)r transmission to 1100 nm.
For absorbance measurements the illumination and collection Gbres were aligned 
at 180 degrees as shown in ûgures 3-2 and 3-3. This experimental set-up for absorption 
spectroscopy shows the mounts holding the 74- UV collimating lenses and fibres for the
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illumination and collection ofligtA 6om the sample. This sample holder was designed 
to accommodate a sample on a microscope slide.
Figure 3-3. Sample Holder, Illumination and Collection Fibre.
3.13. Spectrometer
A USB2000 miniature fibre optical spectrometer from Ocean Optics, Inc. is used 
for the absorbance measurements. The spectrometer has a unique built-in optical bench 
design to dkdxætthwetaollecledligliL
The CKxmponents of the spectrometer optical bench include an entrance slit, 
collimating mirror, grating, facusing mirror, detector collection lens, and frlters aligned 
in an asymmetric crossed Czemy-Tumer geometry and coupled to a CCD detector, as 
illustrated in figure 3-4.
Detector
L2 Detector Collection Lens 
[Grating
Spherical Mnror } Entrance Sût
Focusing tArror
Figure 3-4. Asymmetric Crossed Czerny Turner Design (Ocean Optics, Inc. 2002).
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The entrance slit built into the spectrometer acts as an aperture controlling the 
amount of light entering the optical bench. The entrance slit in this system has a height 
of 1 nun and a width of 25 pm. The light passing through the slit is collimated by a 
spherical mirror that directs the light into the grating far wavelength selection. The 
frxed grating has the best efSciency in the spectral range of 350 nm to 800 nm, with 
maximum efhciency at 500 nm. The light from the grating is projected onto a second 
spherical mirror that focuses the wavelengths onto a collection detector lens (L2) in front 
of the detector. L2 is a cylindrical lens that focuses the light, after it passes through a 
variable long pass order sorting Slter, onto the detector elements. The variable long pass 
order sorting filter (OFLV) eliminates the second and third order effects to the detector 
signal (Ocean Optics, Inc. 2002). The detector is a 2048 element SONY ILX511 linear 
CCD array. The electronic data collected by the detector is reconstructed into an image 
by the software OOIBase 32.
Dispersion, resolution, and optical resolution are properties important ftn 
characterization of system performance. Linear dispersion is associated with the 
instrument's ability to resolve fine spectral detail. Equation 3-1 from Ocean Optics, Inc. 
(2000b) expresses dispersion as:
Equation 3-1. Dispe^om
W 8
Dispersion is therefore dependent on the spectral range of the grating (GSR) and the 
array size of the CCD detector. Resolution is deftned as the minimum difterence in 
wavelength between two wavelengths that can be distinguished. The optical resolution is
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the separation between cut-on and cut-ofT wavelength at 50% of peak transmission 
(FWHM) in equation 3-2 (Ocean Optics, 200b).
Equation 3-2. Optical Resolution.
Optical resolution is dependent on the groove density of the grating (600 lines/nm) and 
the dimensions of entrance slit.
With the spectrometer confrguration previously described, the dispersion is 
0.3174 nm/pixel, the resolution is 4.2 pixels for the 25 pm slit (Ocean Optics, Inc. 
2000b), and the optical resolution is 1.333 nm.
3.2. FLUORESCENCE SPECTROSCOPY AND IMAGING
The combined spectroscopic measurement-imaging system is used for 
fluorescence spectra acquisition. The imaging component facilitates identification and 
selection of particular areas of interest of a tissue sample. In particular, such localization 
of the source from which a spectrum is obtained can clearly be beneGcial when 
interpreting the acquired data. Figure 3-5 shows the system for Guorescence 
spectroscopy and imaging. The basic components of the system are labeled A through 
F The Hght source (A) is connected to an epi-Guorescence microscope (B). Emitted 
Gght from the sample is collected through an adapter (C) and coUecGon Gbre (D) and 
directed to both a spectrometer (E), and the CCD camera (F).
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Figure 3-5. Components for Combined Fluorescence Spectroscopy and Imaging. 
33.1. Light Source
For Guorescence measurements, the excitadon Gght source is a 100 W halogen 
lamp with a brightness control. The brightness control can be adjusted Gom 0% to 
100% of the maximum intensity. The halogen lamp and a coUector lens that Gxmses the 
Gght onto the Glter cube are mounted in the lamp housing.
3.23. Elumimation and Collection
The iGuminaGon and coUecGon opGcs for Guorescence measurements are more 
complex than the tabletop opGcs for absorbance measurements. An epi-Guorescence
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Eclipse E400 microscope^ with an adzq)ter between the eyepiece and Gbre are the key 
components used to illuminate and collect Guorescence signals Gom the sample.
The B-3A Glter cube^ is used for aG measurements with the epi-Guorescence 
microscope. The Glter cube contains an excitation Glter, dichroic beam splitter, and 
emission Glter. The excitadon Glter is a wide band-pass Glter with a wavelength range 
o f420 nm to 490 nm permitting excitation wavelengths within this range to pass through 
the excitation Glter and reGect onto the objective to the sample via the dichroic beam 
splitter. The dichroic beam splitter has a transmission cut-ofr wavelength of 505 nm; 
Gght of wavelengths shorter than 505 nm is reGected onto the objective while that of 
longer wavelengths is transmitted through to the emission Glter. The emission Glter is 
long pass with a wavelength cut-on at 520 nm i.e., Gght from the sample with 
wavelength equal to or above the cut-on are collected. The epi-Guorescence microscope 
has mounts to accommodate up to four filter cubes. Depending on the desired 
qipGcadon, different Glter cubes can be readily selected.
For Gving cells, an incubator was designed to hold the sample and maintain an 
environment that would sustain the cells." The incubator was manufactured using 
aluminum. Two 20 D resistors in paraUel were mounted in the aluminum on either side 
of the sample chamber inserL A constant current was then appGed to the resistors to 
establish a constant temperature. Figure 3-6, shows the microscope incubator. The 
dimensions of the incubator surface are 7.61 cm x 3.32 cm with a thickness of 0,6 cm.
 ̂ Re&r to Appendix m  for Product Information.
" The incubator was a collaborative eSbit between die Medical Physics Dqiartment at the Northwestern 
Ontario Régional Cancer Centre and the Physics Dqiartment at Lakebead University.
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Figure 3-6. Microscope Incubator.
The insert slot has a diameter of 2.75 cm with a nylon screw to tighten the chamber into 
place. The dimensions of the incubator surface are 7.61 cm x 3.32 cm with a thickness 
of 0.6 cm. The insert slot has a diameter of 2.75 cm with a nylon screw to tighten the 
chamber into place. The removable sample chamber has an outer diameter of 2.71 cm. 
When the chamber is sealed with cover glasses, a 400 pm thick chamber is created. The 
top of the sample chamber has an inner diameter of 1.91 cm and the bottom has an inner 
diameter of 2.31 cm. The insert has an overall thickness of 0.5 cm.
An adapter was designed to connect Gbre opGc cable to the eyepiece of the 
microscope. "  Figure 3-7, show two viewing angles of the eyepiece/Gbre adapter.
Figure 3-7. Microscope Eyepiece/Fibre Adapter.
The adapter design was a collaborative eflbrt betweai the Medical Physics Department at the 
Northwestern Ontario Regional Cancer Centre and the Physics Dqiaitment at Lakehead University.
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The eyepiece/Gbre ad^ter Gts over a PVC collar with a diameter of roughly 4.4 cm that, 
in turn, is mounted onto the microscope eyepiece. Figure 3-8, shows the adapter and
PVC collar detached from the microscope eyepiece.
Figure 3-8. PVC Collar (left) and Eyepiece/Fibre Adapter (right).
The adapter consists of a 20 x Newport objective with a numerical aperture (NA) of 0.4 
and a series of tubes, a fibre adapter, and an X - Y translating lens mount. Table 3-1, 
summarizes the components of the adapter, listing the components from the fibre
ThorLabs Inc. Parts Description
SMISMA SMA Fibre Adapter
LMIXY X and Y Translating Lens Mount (+/-1 mm)
SM1L05 1" Tube 1/2" Deep
SM1V05 1" Tube Rotating Adjustment Focus 1/2" Travel
SM1L03 I" Tube 1/3" Deep
SM1A3 Microscope Objective to 1" Tube Adapter
SMIA2 1" Tube to 2" Tube Adapter
SM2V10 2" Tube Rotation Adjustment Focus 1 " Travel
SM2L05 2" Tube Lens Tube 1/2" Deep
connection to the eyepiece. The 400 pm Gbre from Ocean Optics fastens into the 
SMISMA Gbre adapter and the SM2L05 tube lens slides tightly over the PVC collar. 
The otgective is mounted inside the tubing so that the back aperture is at a minimum 
distance from the exit pupil of the eyepiece. The minimum distance is limited by the
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tubing. The X and Y translation mount connecting the Gbre to the adapter to align the 
Gber with the objective is criGcal G)r optimizaGon of the spectral signal.
3.23. Spectrometer
The Ocean OpGcs, Inc. USB2000 m in i a tu r e  Gbre opGc spectrometer discussed 
above &)r absorpGon spectroscopy (re. 3.1.3.) is also used for Guorescence spectroscopy 
analysis. The spectrometer is shown in Ggure 3-5 (E) as a component of the 
Guorescence instrumentation. In figure 3-9, the spectrometer is shown with the USB 
connecGon on the left-hand side of the image and the SMA connector and Gbre opGc 
patch cord connecGon shown towards the bottom of the image.
--------
n  XX XI
Figure 3-9. NGniature Fibre OpGc Spectrometer.
33.4. CCD Camera
Imaging of the sample is achieved using a cooled CCD camera. Cooling of the 
CCD camera is achieved with forced air Gom a thermoelectric cooler. The array size is 
2184 pixels x 1472 pixels, where a pixel is 6.8 pm x 6.8 pm. The maximum imaging 
area is 14.9 mm x 10.0 mm. The CCD camera coGects the emitted photons generated
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from the Guorescence emission of the sample. Approximately 50% of the eyepiece Geld 
of view (FOV) in the 1472 pixels direction and 70% of the FOV in the 2184 pixel
direction is actually imaged by the CCD array. Figure 3-10, shows the sensitivity of the 















































Figure 3-10. CCD Camera SensiGvity (Apogee Instruments Inc.2(X)2).
The quantum efficiency (QE) is the number of electron-hole pairs generated per photon. 
At 400 nm the QE of the CCD camera is 50% and at the peak (^iproximately 620 nm) 
85% of the electron-hole pairs are generated per photon. ^
Refer to Appendix m  6)r Product InAnnatkm.
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4. SAMPLE PREPARATION
Spectroscopic and imaging data were obtained from a variety of samples using a 
number o f different preparation techniques. Reference samples were estabhshed using 
various concentrations of ethidium bromide (EtBr) and frxed tagged cells. Living cells, 
prepared with GFP tags in the nucleus (HI) or in the cytoplasm (Actin), were cultured 
from a breast cancer cell line (MCF-7). Tissue was obtained from biopsy samples of 
normal and cancerous colon tissue.
4.1. REFERENCE STANDARDS
EtBr was estabhshed as a reference standard for spectroscopic purposes because 
it has a well characterized spectrum, is stable, homogenous, and may be readily diluted. 
In total, five different concentrations of EtBr were prepared. The main stock of EtBr^ 
had a concentration of 10 mg/ml, with 50 pi available. From the main stock an 
intermediate concentration is made by pipeting the 50 pi EtBr solution with 9.95 ml of 
distilled water, yielding a concentration of 50 pg/ml (C'smr). To acquire 3 ml of each 
target concentration (50 pg/ml, 10 pg/ml, 5 pg/ml, 0.5 pg/ml, and 0.1 pg/ml) of EtBr, the 
volume of EtBr fr-om intermediate concentration is calculated using equation 4-1.
Equation 4-1. Volume of EtBr. 
uMMugMaMunaanai
From equation 4-1, Vemr is the volume of 50 pg/ml intermediate solution to reach a total 
volume of V% of 3 ml for a target concentration starting from the intermediate 
concentration (C'Etar). Table 4-1, summarizes the volume and concentrations used.
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Table 4-1. Volumes and Concentrations of EtBr.
EtBr Target Concentration 
C*EtBr 
(pg/ml)
Volume o f Water 
Vh20 
(ml)
Volume of EtBr 
Vpm,f6om 50 pg/ml EtBr)
(ml)
Total Volume
Vt (Vh20+ V EtBr)
(ml)
50 0 3 3.000
10 2.4 0.6 3.000
5 2.7 0.3 3.000
0.5 2.97 0.03 3.000
O.I 3 0.006 3.006
For spectral analysis the 3 ml concentrations were syringed into Petri dishes. During 
measurements the Petri dish Gds were taken o ff After the measurements the Petri dishes 
were stored at room temperature with their lids on and sealed with paraffin film. The 
Petri dishes were covered in aluminum foil to protect the solvent ftom long-term 
exposure to light. Precautions, such as wearing gloves, were necessary since EtBr can 
bind to and damage DNA.
43. CELL LINES
A total of six Actin GFP tagged MCF-7 cell samples and six HI GFP tagged 
MCF-7 ceU samples were prepared. MCF-7 is the designation for an established cell 
line for breast adenocarcinoma cells (ATCC No. HTB-22). These cells were tagged 
with green fluorescence protein (GFP) in the cytoplasm (actin) and the nucleus (HI).
The actin GFP tagged and the HI GFP tagged MCF-7 cells are from actively 
growing stock cultures. The cells are incubated at a humidified 37 °C with 5% COz in 
35 mm by 10 mm polystyrene ceU culture dishes^ containing growth medium for 
nourishment. The growth medium used is Gibco RPMI medium 1640  ̂plus fetal bovine 
serum (FBS) and 1% andbioGc-antimycoGc^. A 22 mm no. 1 round micro cover glass^ is 
placed in the culture dish for the cells to adhere and grow. For actin GFP tagged MCF-7
t Refer to Appendix m  for Product Information.
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cells, 1 mM butyrate solution is added the day after the start of incubation. The butyrate 
enhances the GFP expression in the cells. For MCF-7 cells, approximately two days of 
incubation is required for a sufficient number to be plated onto the cover glass. As the 
MCF-7 cells are needed, the growth medium is aspirated out of the culture dish and 
replaced by new growth medium the day of the sample preparation.
An incubator chamber with a depth of 400 pm is used in Guorescence 
measurements of the tagged living cells. A cover glass is Gtted into the bottom of the 
chamber and sealed approximately an hour before filling the chamber with growth 
medium. The plated cover glass is Gtted face down and sealed on top of the chamber. 
Initially sealing of the plated cover glass was accomplished using nail polish. The 
disadvantages were that the nail polish is toxic to cells if there is leakage into the 
chamber and the drying time resulted in lengthy preparation times. The nail polish 
sealing technique was replaced by using thin adhesive spacers^ for the top cover glass 
resulting in an improved ceU preparaGon time.
Once Gie cells are sealed in the chamber, the chamber is placed in the incubator 
where Guorescence measurements were either performed on the tagged MCF-7 cells 
diiecGy, or subsequent to exposure to radiaGon. Although no detectable spectroscopic 
change was anGcipated as an immediate result of eiqxtsure, the living tagged cells were 
irradiated to simply invesGgate the possibiliGes. The incubator is coimected to a voltage 
supply set at 5.0 V and leG to stabilize for roughly half an hour be&rre acquiring 
measurements. A dose of 5 Gy was deUvered to three AcGn GFP tagged and three HI 
GFP tagged MCF-7 cell samples of ^Co gamma rays (135 MeV) prior to performing
 ̂ Re6r to A^xodix m  for Product Ih&rmation.
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Guorescence measurements. During irradiation the sample is set at a distance of 80.0 cm 
Gom the source, at a depth of 0.5 cm with a radiation Geld size is 10.0 cm by 10.0 cm, 
which is a standard geometry in dosimetry. Figure 4-1, Glustrates the irradiation 
geometry far the tagged ceU samples sealed in the incubator chamber.
0 5 cm S oKd Wafer BmH-'ap 
09 cm InoAaferChaaib@r PWdom
17.3 cmSoM Water Bjclocatter
Figure 4-1. Cell IrradiaGon Geometry.
The time required to dehver 5 Gy (or 500 cGy) to the given sample using this 
geometry was calculated using Patient Dose Calculation Version 6.4 (McGhee 2003). 
The calculated times are summarized in Table 4-2. The times vary due to the date of the 
exposures and the decay of the ^Co source.
Table 4-2. Time to Dehver 500 cGy (with F.S. 10 cm x 10 cm , 80 cm SAD,
A s  \   /c_a__
Cell Type Sample Number Time (min)
Actin GFP tagged MCF-7 6 3.59
Actin GFP tagged MCF-7 9 3.60
Actin GFP tagged MCF-7 10 3.60
HI GFP tagged MCF-7 3 3.52
HI GFP tagged MCF-7 5 3.63
HI GFP tagged MCF-7 7 3.64
4.3. TISSUE
A total of 24 colon tissue samples Gom two paGents (PA and PB) were obtained 
Gom biopsy specimens. The samples were ^novided Gom the Biochemistry Research 
Laboratory with six normal and six cancerous samples provided for each paGent The 
biopsy specimens for PaGent PA were surgicahy removed Gom the sigmoid colon. The 
pathology report idenGGed a moderately diGerenGated adenocarcinoma. The surgicaUy
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removed biopsies Gom PaGent PB were taken Gom the cecum and ascending colon. The 
pathology examinaGon identiGed a moderately difterentiated invasive adenocarcinoma.
The randomly shaped colon tissue samples were secGoned to a thickness of 10 
pm. The samples are Grst Gozen using liquid nitrogen, than secGoned using a Cryostat 
(Model Lieca CM 1850 Gom Meyer Instruments Inc.). The secGoned samples are 
mounted to a microscope slide by contact. After preparaGon the samples on the 
microscope slide are stored at room temperature in a microscope slide box. For safe 
handling of the samples, gloves and a face mask were worn. The images and 
spectroscopic measurements were acquired at room temperature at varying times after 
preparaGon.
5. METHODS
Absorption and fluorescence measurements were the two optical spectroscopic 
techniques invesGgated. The experimental methods associated with each of these 
techniques are described in detail in the fallowing secGons (re. 5.1. AbsorpGon 
Measurements and 5.2. Fluorescence Measurements). With all extraneous GluminaGon 
sources extinguished, the laboratory room had an adequate dark seal to minimize 
ambient Gght during aft qaectroscopic measurements. In general, spectroscopic 
measurements were obtained using a "scope" mode, meaning that the measured signal is 
provided as the raw data generated by the analogue to digital (A/D) converter 
incorporated into the spectrometer. These raw data include effects arising Gom the Gght 
intensity, grating reftecGvity, Gbre transmission, and detector response. For absorpGon 
and Guorescence measurements, the raw spectral data were acquired for background 
readings, including dark and/or reGrence spectra, and a sample reading.
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5.1. ABSORPTION MEASUREMENTS
The apparatus used for absorption spectroscopy of colon tissue was discussed 
previously (re. 3.1. Absorption Spectroscopy). The spectra are acquired in "scope" 
mode consisting of the raw data Gom the sample less the dark spectra.
A reference reading is obtained by placing a blank microscope slide in the 
tabletop sample holder between the two collimating lenses of the 400 pm diameter 
illumination and collection fibres. The reference reading and the light intensity are 
significant features influencing selection of an appropriate integration time so that the 
signal does not saturate. A 3 mm Teflon difiusion disc is added into the path of the 
excitation light to simply attenuate the light to the sample by approximately 70%. 
Teflon is used because at these spectral energies all wavelengths are equally attenuated 
so that the overall spectrum remains in essence unaffected. The integration time 
employed for the absorbance measurements of the normal and cancerous colon tissue 
was typically 5 milliseconds. Since the integration time was short, multiple samplings 
were acquired and averaged to improve the signal to noise ratio (SNR). Signal to noise 
ratio is defined as the signal measured relative to the background noise. The signal to 
noise is improved by a factor equivalent to the square root of the number of samplings 
used to establish an average spectrum. For example, with 5 spectra averaged the signal 
to noise is improved by a Actor of ̂ proximately 2.24. The dark spectrum is taken by 
covering the collection lens/fibre with a lens cap to block the light entering the 
spectrometer, the dark subtract collects leakage current Gom the system. To remove the 
dark spectrum fiom the reference, a dark subtract is perGrmed (The dark subtract is only 
applicable in scope mode). Once the background readings have been established with
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set integration times, averaged sample spectra can be acquired by replacing the blank 
microscope slide with the microscope slides containing the 10 pm thick colon tissue 
samples. A tissue sample thickness of 10 pm was selected as a compromise between a 
thin section (give very little absorption) and a thick chunk (high absorption). A timeline 
of the absorption measurements G r the colon tissue is provided in the appendices (re. 
Appendix V).
53. FLUORESCENCE MEASUREMENTS
Fluorescence measurements were acquired Gr various Ethidium Bromide (EtBr) 
concentrations, fixed reGrence cells, living cells, and normal and cancerous colon tissue
samples using the apparatus described previously (re. 3.2. Fluorescence Spectroscopy 
and Imaging). Slightly different methods were used for the cells and tissue samples as 
opposed to the EtBr sample measurements.
For fluorescence measurements of various concentrations of EtBr, reference 
spectra, dark spectra including dark subtract, and sample spectra were acquired. For 
each set of measurements the microscope stage was adjusted G 14 cm ± 0.05 cm below 
the filter cube holder. The reference reading is obtained by placing a Petri dish with 3 
ml of distilled water on the microscope stage. A maximum light intensity fiom the 
halogen light source was qiplied and an inGgration time of 2 s Gr the spectrometer was 
selected. The inGgration time of the spectrometer is the period in which the detecGr 
collects the emitted phoGns. The dark spectrum was then obtained with the shutter on 
the microscope closed. The dark spectrum correction is then ^ l i e d  G the spectrum 
fiom the distilled water reGrence. Sample spectra are subsequently obtained by opening
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the shutter and replacing the distilled water with a Petri dish containing 3ml of a known 
concentration of EtBr.
To acquire Guorescence measurements of the cells or tissue samples, the CCD 
camera is Grst cooled down G -13 °C. A temperature of -13 °C was Gund G be the 
optimal temperature Gr imaging in our lab environment due G airGow and room 
temperature Guctuations. The Gxed reGrence ceGs are Gcused in the Geld of view with 
a light intensity of approximately 70% of the maximum intensity. A higher light 
intensity would phoG-bleach the sample causing the Guorophore intensity G decrease. 
ThereGre G minimize photo-bleaching Ge Gght intensity was iqipGed depending on Ge 
brightness of the sample as observed through Ge eyepiece. The light intensity of 
approximately 70% was set by adjusting Ge brightness control for Ge halogen light 
source where a scale ranged from zero (minimum) to ten (maximum) Focusing of Ge 
image is achieved through a combination of appearance via the eyepiece directly and 
observation of CCD images. To ensure that Ge spectrometer is detecting Gght from a 
localized area of the sample, Ge iris size on the microscope is adjusted to boG the 
minimum and optimum diameters G r each of 40 x and 60 x objectives. The minimum 
iris size ensures the aGgnment of the eyepiece/Gber adapter and centers a given sample 
area containing one cell m Ge Geld of view. The optimal iris size approximates the 
coUection area of Ge Gber. For a given sample area, an image and a corresponding 
spectrum are acquired G r Gese configurations of Ge two diameter sizes for each of 40 x 
and 60 x objectives. These measurements were conqxued G Ge initial measurements 
taken at Ge time of the eyepiece/fibre ad^ter aGgnment. These measurements served as 
a reference reading G ensure that the ad ^ ter remained aGgned and that Ge iris size was
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kept ^yproximately Ge same. Once the optimum iris size is established, Ge system is 
focused on the living cells or tissue samples o f interest and an mtegration time giving an 
optimal signal is chosen. Table 5-1, shows the typical integration times and light 
intensities used m fluorescence measurements of the various samples. The Gght 
intensity (% of Ge maximum intensity) is selected Gr each sample area based on Ge 
observations of the emitted fluorescence intensity as seen through Ge eyepiece.
Table 5-1. Spectrometer Integration Times and Light Intensities for Fluorescence 
Measurements.
Sanq)le Type Light Intensity(% o f Maximum Intensity)
Integration Time
(s)
Fixed Tagged Reference Cells 70 3to5
Actin GFP MCF-7 Cells 50 9
HI GFP MCF-7 Cells 50 9
Colon Tissue - Patient PA 70 12
Colon Tissue - Patient PB 70 12
To facilitate inter-comparison of data acquired from different samples, the light mtensity 
and mtegration time were kept constant for each sample type. Using Ge selected 
mtegration time, a dark spectrum is again acquired wiG Ge shutter on Ge microscope 
closed, blocking Gght from reaching the spectrometer. Application of Ge dark subtract 
has a net effect of decreasing the signal noise. Spectra were then acquired G r the area of 
mterest, immediately GGowed by acquisition of an image of the same area of mterest. 
For Gving breast cancer ceUs the acquisition of fluorescence images and fluorescence 
spectra were obtained at 5 minute intervals over a period of approximately 4 hours. 
WiG the colon tissue samples, the fluorescence measurements were repeated twice Gr 
two different areas on each sample. To obtain a clear image of the sample area, Ge 
cooled CCD cameras exposure time was set G 5 seconds wiG a binning of 2. The 
binning averages Ge Gur nearest pixels as discussed m Section 2.3.3. A timeline for
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the fluorescence measurements of Ge Gving ceU line and the colon tissue samples are 
summarized m the appenGces (re. Appendix V).
6. ANALYSIS AND RESULTS
The analysis and results are presented m the same sequence as the methods (re. 
5. MeGods), and is further Gvided mG raw spectra and images, normalized spectra, and 
spectral differences. The significance of Gè results acquired for Ge absorption and 
fluorescence measurements are presented m Ge Gscussion (re. 7. Discussion). G  
general, Gr the two distinct measurement techniques used, absorbance and fluorescence, 
Gere were different limitations on Ge spectral range acquired. Absorbance spectra were 
acquired for normal and cancerous colon using a tungsten halogen lamp wiG a 
wavelength range of 360 nm to 2000 nm as the light source. Fluorescence 
measurements were acquired for five concentrations of EtBr, fixed tagged cells, livmg 
Actin and HI GFP tagged MCF-7 cells, and normal and cancerous cGon tissue using 
excitation wavelengths o f420 nm G 490 nm. Fibre and qiectrometer combinations used 
imposed another limitation as detection response was restricted G the wavelengG range 
of 350 nm to 1000 nm (re. 3.1.3). For boG absorbance and fluorescence measurements 
of the colon tissue samples, the acquired data G r each group of six samples for the two 
patients and two tissue types have been defined as a "spectral set".
6.1. ABSORBANCE SPECTRA
6.1.1. Raw Absorbance Spectra for Colon Tissue
Three spectral sets Gr absorbance at different locations on each normal and 
cancerous colon tissue sample were acquired G r each of Ge two patients. Note that the
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absorbance spectra are in 6 ct the transmitted intensif through the tissue sample. Three 
sets of absorbance spectra were acquired in an eSbit to verify the consistency of 
absorbance bends. Data cwre^omhng to  e a ^  padent ia ^sdngm ^ed by uâng the 
labels PA and PB. A total of 36 spectra &om 6 normal and 6 cancerous colon samples 
were accumulated for each patient. The raw absorbance spectra of colon tissue are 
iüusbîded in 6gw es6-l for p a d ^  PA and dgme 6-2 ^  padent PB.
P A N  - Spectral Set 1 
PA C  - Spectral S et 1 
P A N  - Spectral Set 2 
P A C  - Spectral Set 2 -
P A N  - Spectral Set 3 
PA C  - Spectral Set 3
oc VI ÛC CN iri o o « — « n o o r —
W avelen th  (nm)
Figure 6-1. Raw Absorbance Spectra for Colon Tissue of Padent PA.
 PBN - Spectral Set 1
 PBC - Spectral Set 1
 PBN - Spectral Set 2
 PBC - Spectral Set 2
 PBN - Spectral Set 3









Figure 6-2. Raw Absorbance Spectra for Colon Tissue of Padent PB.
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The absorbance spectra for both patients are an average of the 6 sample spectra for each 
of the three spectral sets. The spectra are comprised of data obtained within a 
wavelaigth r^ g e  of 350 imai to 1000 rma. The maximwn intaisities vary 6om  ̂ eetral 
set to spectral set. For normal colon tissue spectra, the PAN data have a maximum 
intensity ranging 6om approximately 550 counts to 1000 counts (re. Figure 6-1) while 
th ^  ^  6 e  PBN data ranges âtm i 700 cow ts to 1300 counts (re. Figme 6-2). Fw 
cancerous colon tissue spectra, the PAC data has a range of approximately 900 counts to 
1900 counts (re. Figure 6-1) while the PBC data ranges from 700 counts to 1500 counts 
(re. Figure 6r2). These vananees can be ^bihibed to  d e^^d ^m es on 6 e  area of the 
sample, variations in the sample set-up, and the time that elapsed after sample 
preparation (re. 7.1. Absorption Spectroscopy for further discussion). The spectral data 
were Aen normalized in an attempt to  minimize the effects o f some of feese rmdeshable 
contributions.
The areas of 6 e  spectra w%e calculated by summing 6 e  spectral m tatsities (S) 
using equation 6-1.
Equation 6-1. Spectral Area.
Speca?' Area -
The variable S(X) is the intensity for the given wavelength range of 350 nm to 1000 nm. 
The specbalW œ sitiesw ^acqm red at 036 n m in a ^ iœ ls  far Ae204&elŒtent linear 
CCD array in the spectrometer. Table 6-1, expresses the spectral area of a spectral set as 
a ratio to the average area of all spectral sets and tissue types for each patient As can be 
readily olxKrved, specbal characteristics ^ so  vary. One measure n f fhia variation i t  the 
ratio of spectral areas acquired for each spectral set (re. Equation 6-1) over the average
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Ratio of Area to 
Average 
(aU six) per Padent Sample





2 PAN 0.55 PBN 0.77
3 0.57 0.88
1 1.94 1.56
2 PAC 0.96 PBC 0.74
3 0.93 0.74
Fœ p ^ en t PA, A eradeofA e specba areas for 6 e  normal and c ^ e a o ^  colon dsmes 
were shown to vary from a minimum of - 45% to a maximum of + 94%. For patient PB, 
the ratio of the spectral areas for the normal and cancerous colon tissue samples varied 
from a minimum of -  26% to  a  maximum ^  + 56%. For bo6  padents the rado of 
spectral areas was found to be greater for spectral set 1 compared to spectral set 2 and 
spectral set 3. For a discussion of these results re6 r to 7.1. Absorpdon Spectroscopy. 
NermaWze# Absorbance Spectra (or Tiswe
The individual raw absorbance spectra of colon tissue were normalized to 
remove less desirable experimental consideradons (i.e. sample thickness). The spectral 
data w%e norm^ized using a Borm*dizadw rado of 6 e  avMage area to  the q)ectral «ea. 
The normalized intensides (NI) were calculated using equadon 6-2.
Eqoadon 6-2. Normalizadon of Spectral Data.
A' ĉ.:ag:A re
Again S(X) is the raw spectral reading for a given wavelength, the spectral area is 
calculated uang equadon 6-1, and the average area is calculated Ae specdal areas
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
59
obtained 6om each spectrum in a given spectral set. For boA patients 6 normal and 6 
cancerous colon tissue spectra were acquired for each spectral set. This normalization 
method yields Ae same area imderAecmve A ra g iv e n p ad ^ .
The normalized spectra data is re-analyzed A Acilitate comparison between 
cancerous A normal colon tissues Ar the same padent as well as an inter-padent 
cwqtarison Ar Ae s*me cokm dssue types (Le. A  and cancerous A
cancerous).
For the same padent comparison the averages of Ae normalized spectral areas 
A r each of Ae nommai :md cMK:eousi^ecbal sets w æ c alculaAd(A vŒ ageh^, and Ae
average area was recalculated to determine Ae renormalized mtensities using equation 
6-3.
Equation 6-3. Renormalized Spectra.
Average Area
, Average Normomiaized Area
The term m Ae brackets of equadon 6-3 is the renormalizadon rado used A acquire the 
same ^ecdai areas betw e% ^ectral sets Arcona^arisim between cancerous and n ^ a a l 
colon tissues 6om the same padent Table 6-2 shows the renormalizadon rado (the 
average area A Ae average normalized area) Ar each spectral set Ar boA normal and 
caacerouscolon tissue m Ae Aiid column, :md Ae radoof Ae rœ orm dizedareasA A e 
average area A r each padent m the AurA column Ar the three spectral sets of padents 
PA and PB.
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Po" Spectral Set 
(re. Equation 6-3)
Ratio of Renormalized Area to 











PAN T3Z 0.753 PAG 0.81
1





For patients PA and PB the renormalization ratios (column 3) were used A  calculate the 
renormalized data (re. Equation 6-3). The renormalization ratio for PAN was 
consistently M^jer compmed A  PAC, whereas Ar patient PB the renormalization rados 
were similar for both Ae normal and cancerous colon tissue. For patient PA Ae ratio of 
Ae renormalized areas (column 4) vary 6om a minimum of -  25% A  a maximum of + 
49% w hae as fm padent PB Ae rado Ae ava% e normtdized areas vary dom a 
minimum of -  25% to a maximum of + 44%. As observed Ar Ae raw absorbance, Ae 
r^ io s o f the areas w æ  Atmd A  be greats A r Ae drst specbal set compared A  Ae 
second and third spectral sets. The importance of these rados are discussed furAer m 
the discussion (re. 7.1 Absorpdon Spectroscopy).
Figmes 6r3 ̂ d  6-4 show the renormahzed specAa A r p^iŒd PA and A r pA ie^ 
PB req)ecdvely, A AcilitaA comparison between the cancerous and normal colon dssue 
(same padent comparison).





PA N  Spectral Set 1 
PA C  Spectral Set 1 
P A N  Spectral Set 2 
PA C  Spectral Set 2 
P A N  Spectral Set 3 
PA C  Spectral Set 3
W av e len g th  (nm )
Figure ë-3. RencmnaHzed Spectra o f Cokm Tissue (N and C) 6m n Patient PA.
PBN Spectral Set 1 ' 
PBC Spectral Set 1 
PBN Spectral Set 2 
PBC Spectral Set 2 
PBN Spectral Set 3 
PBC Spectral Set 3 -
23 1200
ï s t n m f s —' Oe o v ^ r ' f' ç f 0 0 » - i ‘r i 0 0 ’--i t n c o —m m TT ^  vi  t r » v ^ \ o v o  0 t ^ t ^ t ^ o o o o o o o o o s C ? > O N
W avelength (nm)
Figure 6-4. Renormalized Spectra of Colon Tissue (N and C) 6om Patient PB. 
From Ggure 6-3, the renormalized spectra for the normal and cancerous colon tissue 
froan jpatieot had joaaadrmrm iateruakies raaagiai; 6om  a*;prB9&waaa&&bp <x»urdsit*> 
1450 counts. For each spectral set the cancerous tissue spectra for patient PA were 
shifted. For the wavelength range of 450 nm to 550 nm an average shift of 4 nm ± 2 nm 
wsu&determirMxlL ]FcKthK:T#m&veie*igthi3uagf;()f 'ZfKliamto {%50rur&tliL&iavea%yge shift was 
found to be 5 nm ± 3 nm. These shifts were determined by the mean difference over the
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given wavelength range and the uncertain^ is determined 6om the standard deviation 
(re. Appendix IV.i. for the standard deviation equation). Further analysis including the 
uuaceadawaiCy is all cfuoned cmt lasiryg tbis rcwadicKi uwalesffoWaeiwise spb&kad. Ixar arKi 
PBC the maximum renormalized intensities range frcwri fgyproximately 700 counts to 
approximately 1400 ccnirAsfcMrtlwslliree spectral sets (re. IFigpire 6.4.). For each spectral 
iMzttlie cancerous tLs8u*;sg&ectiakf%xrf)atient MBLwsaee sbiftedL F\)r die waivelerqgth rai&geof 
450 nm to 550 nm an average shift of 5 nm ± 3 nm was determined whereas, an average 
shift of 8 nm ± 4 nm was detomioed for the wavelength range of 750 nm to 850 nm. 
Bodi spectral set 1 p*^ents PA and PB yielded the Wgh^ intœâtie% vA æ as 
spectral sets 2 and 3 yielded similar intensities.
The absolute values of the spectral differences were calculated between the 
cm cwm s and n r^ d ^  ^ ecb a  in equation 6-4 each spechnl set far PA ^ d  PB where 
the sign of the difference is ignored.
Equation 6-4. Spectral Difkrence.
The absolute values of the spectral difkrences were plotted with the calculated data 
fr8*rteqpmtkm aswi a <3aaasaianfàt shMawainiàqgure ëi<5. .At GaauBswrn fit Tamas chwasen 
due to the general i&bagpe of the spectral difference curves. In general, the Gaussian fit 
conforms well to die data except in the region between the two main peaks. Table 6-3 
simimarizxa&tlM jBftwag;;N&rarBKd*ac&<)btairK;dfcK tbetjümssianfittxitlie spexzbRildahL
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FAC-PA J» !î ̂  I ̂  ee 1 
Gftuss bn Fit

















W âv ek î^ ti (urn)
Figure 6-5. Plots of Spectral Difference PAC-PAN (left), 
and PBC-PBN (right) for Colon Tissue.

















2 PAC-PAN 536 98 I 532 95
3 535 99
1 749 147
2 PAC-PAN 778 149 1 770 149
3 782 150
1 536 100
2 PBC-PBN 540 101 1 538 100
3 538 100
1 784 161
2 PBC-PBN 788 154 2 785 155
3 783 151
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For PAC-PAN the Grst peak had a maximum at 532 nm and a full widdi half maximum 
lof Î101, arwi tiw: SKXxoiwi fxaak Ihawl a maximum 77X) inii arid ;i full Tvidtli half 
naaxinMmiofl49Mk FwPBC-P^3the&stpeakhad& maximwmatSS& nm aBdafuIl 
width half maximum of 1(X) nm, aiwi die second peak had a maximum at 785 iini aiMi a 
hill width half maximum of 155 nm.
The area auder &e qieckai difEer^ce cwvea were cakulated hy summmg &e 
intensity differences for 350 nm to 1000 nm (re. Equation 6-1 and 6-4). The ratios of 
areas of the spectral difkrence to the average area hir each spectral set are summarized 
int^)ie6-4.
Table 6-4. Ratio of Area of Spectral Difference for Colon Tissue.
Ratio o f Area to Ratio of Area to Ratio of Area to
Sample Average Spectral Average Spectral Average Spectral
Difference Difference per Patient Difference per Patient Difference per Patient
Spectral Set 1 Spectral Set 2 Spectral Set 3
PAC-PAN 0.78 0.85 0.70
PBC-PBN 122 145 130
In general, the ratios of spectral differences were hiund to be greater &r patient PB 
compared t» padaü PA. The radoa of spec#^ (h@aœee between 6 e  cancerous tmd 
normal spectra of patient PA had a minimum of -  30% for spectral set 3 and a maximum 
of -  15% for spectral set 2. The ratios of spectral difkrence between the cancerous and 
nonnadspechaof pf^ent PB h» the d^ee ^echal sets %%e6tmd to have a minimm nof 
+ 15% for spectral set 2 and a maximum of + 30% for spectral set 3. This fqiproach is 
applicable to compare more than two data sets, although only two are available, as a 
result 6 e  ratios add up to 2.00 fwea(h^»eGhaI set.
For the inter-patient comparison the averages of the normalized spectral areas for 
the normal tissue spectra for both PA and PB were calculated (Average NI), and the
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average area was then recalculated to determine the renormalized intensities using 
equation 6-3. The term in the brackets of equation 6-3 is the renormalization ratio used 
t»  acqwre 6 e  same spectral areas between spectral sets to con^wre betwew 6 e  same 
colon tissue types (i.e normal) 6om the different patients. Table 6-5 summarizes the 
renormalization parameters for the inter-patient comparison. For each spectral set, the 
renr^WizaWon rados shown m 6 e  ^ r d  c ^ u ^ t  « e  the average weas to  6 e  ^echal 
areas, and the ratios of the spectral areas to the average areas for all the normal tissue 
data were calculated in the 6)urth column. The same was done separately for the 
cancero u stissu eh x^A e& fk r^pad ^ ts.




per Spectral Set 
(re. Equation 6-3)
Area to Average Area 
(All Three Spectral Sets) 
per Tissue Type 
(re. Equation 6-1)
1 PAN 1.12 1.38PBN 0.90
PAN 1.18
0.772. PBN 0.87
X PAN 125 a.833 PBN 0.83
1 PAC 0.90 1.53PBC 1.13
PAC 0.88
0.742 PBC 1.16
PAC 0.89 0.733 PBC 1.14
The renormalization ratios (column 3) were applied to calculate the renormalized data to 
acquire the same spectral areas between spectral sets to compare between the same 
dssue <̂pe& &om̂  d i f ^ ^  p^@d& Fw normW  ̂ tissue Ae rœMmWizadw rados f*  
patient PA are greater than that for patient PB. In contrast, for cancerous tissue the 
renormalization ratios for patient PB are greater than that for patient PA. The ratio of 
renormalized areas lor each spectral set to  the average r^imnW ized area all ^)ectral
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sets for each tissue type were calculated (column 4). With this ratio a minimum of - 23% 
and a maximum of + 38% for the normal colon tissue samples and a minimum of - 27% 
and a maximum of + 53% fw the cancaous colon tissue sau^lea were detamined. 
Figure 6-6 illustrates the inter-patient comparison of normal tissue spectra for both 
patients PA and PB, and the cancerous tissues spectra 6)r both PA and PB are presented 
in 6guK 6-7. The impwt*mee of &e inta-p«^em compaiscms fw absoqidon 
spectroscopy between patients PA and PB are discussed in the discussion (re. 7.1. 
Absorption Spectroscopy).
R en o rm P A N  Spectral Set 1 
R en o n n  PBN  Spectral Set 1 
R enorm P A N  Spectral Set 2 
R enonn  PBN  S pectral Set 2 
R enorm P A N  Spectral Set 3 
Renorm  PBN  Spectral Set 3
.S 400
r r o o » - i w i  00 — r - o r n s c o x  — " T r -^ s o S f * ' t ^ r * ‘ Ooeeoo
W aveleng th  (nm)
Figure 6-6. Renormalized Spectra for the Inter-patient of Normal Colon Tissue.
K en o im P A C  Spectral Set 1 
R enom i PBC Spectral Set 1 
R enorm  PA C  S pectral Set 2 
R enorm  PBC Spectral Set 2 
R enonn PAC Spectral Set 3 
R en o n n  PBC Spectral Set 3
§ g g
W av elen g th  (nm)
Figure 6-7. Renormalized Spectra for the Inter-patient of Cancerous Colon Tissue.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
67
The normal tissue comparison showed maximum peak intensities 6om about 650 counts 
to 1150 counts between the three spectral set. The cancerous tissue comparison had 
maxhnnm int^sity  peak» of roughly 800 counts to 1700 counts betw e^ &e three 
spectral sets.
From the renormalized data the spectral diSerence was calculated with equation 
6-5 to compare same colon tissue types (i.e. normal to normal and canc^ous to
cancerous) between patients PA and PB (inter-patient comparison).
Equation 6-5. Inter-patient Spectral DiSerence.
I^pcc >' jkc no. >■£.&.! acdP A - .\j3non.iali.iedFpj
The absolute values of the inter-patient spectral diSerences for the three spectral sets 
were plotted with the calculated data from equation 6-5 and a Gaussim fit shown in 
figure 6-8. Because of the general shape of the spectral difference curves, a Gaussian 
line shape was chosen to perform a fit to the data. With the inter-patient spectral 
#fiiaeac0  data for cokm fissue, two main peaks are observed. In g ^ 8 ^  &e Gaussian 
fit conforms well to the inter-patient spectral difierence data except in the region 
between the two main peaks (re. Figure 6.8). Table 6-6 summarizes the fitting 
parameters (peak maxima and w i^ )  obtained fin 6 e  Gmissian fit to the ̂ ^echal d ^
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Figure 6-8. Plots of Inter-patient Spectral Difkrences PAN-PBN (leA) 
and PAC-PBC (right) for Colon Tissue.


















2 PAN-PBN 462 197 I 542 158
3 537 105
1 876 108
2 PAN-PBN 748 399 2 803 229
3 784 179
1 541 106
2 PAC-PBC 548 110 1 541 120
3 533 143
1 793 159
2 PAC-PBC 796 160 2 795 189
3 795 247
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For PAN-PBN the Srst peak had an average maximum positioned at 542 nm and an 
average full width half maximum of 158 nm, and the second peak had an average 
maxinaum poâtimaed at 803 mn and an ava% e fWl width half maxmiŒa of 229 nm. 
For PAC-PBC the Srst peak had an average maximum positioned at 541 nm and an 
average full width half maximum of 120 nm, and the second peak had an average 
maximmn portioned at 795 and an average fidl w id6 h ^  maximum of 189 mn (re.
7# 1. Absorption Spectroscopy for a discussion of these results).
The areas under the curves were calculated by summing the spectral difference 
(re. Equation 6-1 æwl 6-5). The r^ io so f 6ese ^ ea sto  6 e  averse  mea 6*̂  each qtectral 
set are summarized in table 6-7.












Difference per Tissue 
Type 
Spectral Set 3
PAN-PBN 0.61 (LS4 L37
PAC - PBC 1.39 1.46 0.63
Fw the normal cokm tisaie the rmin of meas for the ^»ech^ diffa^ice vmy between a 
minimum -  46% and a maximum of + 37% for the three spectral sets. The ratio of 
spectral difference far cancerous colon tissue samples was calculated to be within a 
nnmmwn -  39% and a maximum of + 46% for the tk ee  q>ectral sets. Ahhot%h the 
intent of the analysis format is to compare more than two data sets, only two are 
available. The ratios are, therefore, symmetric about the mean since only two separate 
grcMq)s are investigated for a given :^)ectral set.
A summary of the absorbance spectroscopy analysis is given in the appendices 
(re. Appendix VI.i. Analysis Summary for Absorption Spectroscopy for Colon Tissue).
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6^. FLUORESCENCE SPECTRA AND IMAGES
6.2.1. Raw Fluorescence Spectra for ElBr
The ethidium bromide (EtBr) samples of 50 pg/ml, 10 |ig/ml, 5 pg/ml, 0.5 pg/ml, 
and 0.1 pg/ml woe establiAed as reference standards. In total, 12 fluorescence q)ectra 
were obtained for each concentration oyer time. Figure 6-9 presents the raw 
fluorescence spectra obtained using these EtBr sample concentrations for the emission 
range of510nm  to 800 nm. The fluorescence q>ectra were acquired the 350 mn to 
1000 nm range, although the range of 510 nm to 800 nm was chosen to display the data. 
This portion of the entire wavelength range was chosen due to the dichroic mirror and 
emissnm 51ter parameter of the filt^  cube (re. 3.22.), tmd the signal obtained 6om the 
samples. As a result there was little to no signal detected between 350 nm and 509 nm. 
Also, at wavelengths greater than 800 nm again there was little to no signal detected.
2000
 A vg. Raw Spectra 50 ug/ml
 Avg. Raw Spectra 10 ug/ml
 Avg. Raw Spectra 5 ug/ml
 Avg. Raw Spectra 0.5 ug/ml











Figupc 6-9.̂  Raw FluMescatce Spectra Et&.
The fluorescence spectra shown are an average of the 12 spectra for each concentration. 
The maximum intensity, located at a wavelength of 628 nm ± 5 nm, ranges 6om 
^^noximately 5 cotmts 6)r an EtBr concentr^ion of O.I ^tg/ml to 2100 cotmts fw  an
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EtBr concentration of 50 pg/ml. In 6gure 6-9 the average raw spectra for the 0.5 ^ig/ml 
and 0.1 pg/ml concentrations of EtBr are difScult to see since there fluorescence 
W enâties me mudi lower coEi^wed to the W ghe ctmeedrmkms of Et%  (5 pg/ml, 10 
pg/ml and 50 pg/ml).
The area under the curve was calculated using a summation over the wavelength 
rangeof510nm to800nm (re.Equ^ioD 6-lX  TaWe6-8summarizesthesemeasA)rthe 
average raw spectra and the standard deviation from the mean for the 12 spectra for each 
concentration.







Spectral Area over 
Concentration 
(counts/[pg/mlJ)
Error of Spectral Area 
over Concentration
(counts/[pg/mlJ)
50 661000 67000 13220 1340
10 360000 49000 36000 4900
5 85000 12000 17000 2400
0.5 7000 3000 14000 6000
0.1 -1000 2000 -10000 20000
The spectral area (colimm 2) is shown to deaease from :qq»oximately 661000 counts ± 
67000 counts to -1000 counts ± 2000 counts (which is essentially 0 counts due to the 
negative value) as the concentration of EtBr decreases from 50 pg/ml to 0.1 pg/ml. The 
ratio of the qiectral area to the «mcafrration is ^rown to range from -1(X)00 
counts/[mg/ml] ± 20000 counts/[mg/ml] to 36000 counts/[mg/ml] 1340 
counts/[mg/ml], indicating that there in a nonlinear relationship between the spectral 
area and the concentr^ion <d^theEt&.
A summary of the fluorescence spectroscopy analysis of EtBr has been provided 
in the appendices (re. Appendix VI.ii. Analysis Summary fr)r Fluorescence Spectroscopy 
for Ethidium Bromide);
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
72
6.2^. Raw Fluorescence Measurements for Fiied Tagged Reference 
Cells
Before fluorescence spectra and images of colon tissue or living cells were 
obtained, measurements of Sxed tagged cells were acquired for 40 x and 60 x objective 
magnifications with a minimal and an optimized iris size. These measurements were 
performed as previously discussed (re. 5.2. Fluorescence Measurements). Data acquired 
6)r the 6xed cells were compared to the results obtained during the initial alignment of 
the eyepiece/Gbre adapter to ensure consistency. In total, 13 spectra were acquired for 
the minimum and optimum iris size for each of the two objective magnifications. Figure 
6-10 shows the average raw spectra for the 40 x and 60 x objective magniGcations with 
minimal and optimal iris sizes for the wavelength range of 510 nm to 800 nm.
3000 1
 Avg. Raw Spectra 40xMin
 Avg, Raw Spectra 40xOpt
 Avg. Raw Spectra 60xMin
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Figure 6-10. Raw Fluorescence Spectra for Fixed Tagged Reference Cells.
The raw Guorescence spectrum for each case was calculated by averaging the 13 spectra 
obtained. The maximum intensity occurs at approximately 555 nm ± 5 nm for these 
Gxed tagged cells. The minimum iris yields maximum intensiües in the range of several 
hundred counts for the two objective magniGcaGons. On the other hand the optimal iris
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size provides maximal intensities on the order of several thousand counts for the two 
magniGcations
Using equaGon 6-1, the spectral areas were calculated for the average raw spectra 
of the Gxed tagged cells for both objecGve magniGcaGons with the minimum and 
optimum iris size. Table 6-9 provides the total number of spectra obtained and the 
values calculated for the spectral areas of the Gxed tagged cells.
Reference Sample No. ofSpectra
Spectral Area 
(Counts)
40 X Magnification - Minimum Iris 13 76000
40 X Magnification - Optimum Iris 13 596000
60 X Magnification - Minimum Iris 13 122000
60 X Magnification -  Optimum Iris 13 1060000
For the 40 x objective magniGcation and 60 x objective magniGcation the spectral areas 
for the minimum and optimum iris size have an uncertainty of ± 1000 counts. 
Compared to the 60 x objective magniGcation the spectral areas are 59 ± 3% greater than 
the spectral areas 6)r the 40 x objecGve magniGcaGon corresponding for each of the 
minimum and optimum iris sizes.
Fluorescence images were acqinred in coiyuncGon with Gie Guorescence spectra 
in order to ahgn the rekrence sample and set the optimal iris size. Figure 6-11 shows a 
series of four typical images G)r the corresponding magniGcaGons and iris sizes far the 
Gxed tagged cells. Images 6-11(a) and 6-11(c) represent the area of the sample that is 
centred in the overall Geld of view with m in im u m  iris size to acquire the corresponding 
spectra 6)r 40 x and 60 x objecGve magruGcaGons respecGvely. Images 6-11(b) and 6- 
11(d) show the optimal iris size that approximates the coUecGon area of the opGcal Gbre 
through the eyepiece.
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Figure 6-11. Fluorescence Images of Fixed Tagged Reference Cells (a) 40 x Min Iris, 
(b) 40 X Opt Iris, (c) 60 x Min Iris, and (d) 60 x Opt Iris.
An analysis summary for the fluorescence measurements of the flxed tagged 
reference cells is given in the appendices (re. Appendix Vl.iii. Analysis Summary for 
Fluorescence Measurements far Fixed Tagged Reference Cells).
6.23. Raw Fluorescence Measnremenls for Actin and HI GFP Tagged 
MCF-7 Cells
In total 512 fluorescence images and 512 fluorescence spectra were obtained 
using living Actin GFP tagged MCF-7 cells and HI GFP tagged MCF-7 cells. The 
living GFP tagged MCF-7 cells samples were either non-irradiated or irradiated with 5 
Gy of ^Co gamma rays. A dose of 5 Gy is a high dose compared to a more typical 
flactioned dose of 2 Gy to 2.5 Gy received by a patient on a given day during a 
treatment. Table 6-10 shows a breakdown of the cell type, sample number, radiation 
dose delivered and total number of images and spectra. Three samples of each cell type
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were irradiated and three samples were not, yielding 128 images and 128 spectra for 
each radiation dose and cell type.
Cell Type Sample No. RadWmDose No. of Images No. of Spectra
3 0 49 49
4 0 49 49
Actin GFP MCF-7 6 5 49 49
7 0 30 30
9 5 49 49
10 5 30 30
2 0 49 49
3 5 49 49
HI GFP MCF-7
4 0 49 49
5 5 49 49
6 0 30 30
7 5 30 30
The average raw fluorescence spectra for all the Actin GFP tagged MCF-7 cells 
and HI GFP tagged MCF-7 cells are shown in figures 6-12 and 6-13, respectively. The 
fluorescence spectra for the living Actin GFP tagged MCF-7 cells and the HI GFP 
tagged MCF-7 cells were acquired for the 350 nm to 1000 nm range, aldiough the range 
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Figure 6-12. Average Raw Fluorescence Spectra of Actin GFP Tagged MCF-7 
Cell Samples.
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Figure 6-13. Average Raw Fluorescence Spectra of HI GFP Tagged MCF-7 
Cell Samples.
There is no apparent difference between results obtained &om the non-irradiated and 
irradiated cell samples. For the Actin GFP tagged MCF-7 cell samples, the maximum 
intensity ranges from a minimum of about 700 counts to about 1400 counts at about 526 
nm ± 5 nm. For the HI GFP tagged MCF-7 cell samples the maximum intensity ranges 
6om about 150 counts to 300 counts at 526 nm ± 5 nm. For both the Actin GFP t%ged 
MCF-7 cells and HI GFP tagged MCF-7 cells there is a slight shoulder after the main 
peak. For the HI GFP tagged MCF-7 cell samples there ^>pears to be a slight peak near 
626 nm. The spectral areas of each of the average spectra were calculated for Actin GFP 
tagged MCF-7 and the HI GFP tagged MCF-7 cell samples. The ratios of the spectral 
areas relative to the average area for each cell type are summarized in the fourth column 
of table 6-11.





Ratio of Area to 









HI GFP MCF - 7 6 1.133 1.04
5 5 0.94
7 1.18
For the Actm GFP tagged MCF-7 cells the ratios of spectral area for the non-irradiated 
and irradiated cells vary 6om a minimum o f -  24% to a maximum of + 44%. The ratios 
of spectral areas for the non-irradiated and irradiated HI GFP tagged MCF-7 were 
within a minimum of -  35% to a maximum of + 18%.
Generally, before acquiring any fluorescence measurements, an area of interest 
on the sample is chosen to image over a given time period that ranged ûom 2.5 hours to 
4 hours. The criterion for choosing an area of interest was a combination of the view 
th rou ^  the microscope, and the number of cells in the 6eld of view. During the 
measurement time period the image in the Geld of view changed depending on the 
activity of the sample. Figure 6-14 shows a sequence of 3 images for Actin GFP tagged 
MCF-7 sample 3, a non-irradiated sample, taken at times t = 0 h , t  = 2h05 min., and t = 
4 h 10 minutes. The time t = 0 h represents the initial measurement taken aAer the 
sample preparation in the incubator, mounting, focussing, and cell incubator temperature 
stabilization. The images illustrate the activity of the sample in the Geld of view. The 
lighter shades represent the Guorescence Gom the GFP in &e ceU cytoplasm. One 
readily observable variaGon in the time progression of the images is the movement of
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cells Initially at Ihe centre of the Geld of view towards the upper leA comer. Changes in 
the shape of the cells can also be observed.
Figure 6-14. Image Sequence of Actin GFP tagged MCF-7 Sample 3.
Figure 6-15 shows a sequence of 3 images for Actin GFP tagged MCF-7 sample 
6, irradiated with 5 Gy of ̂ Co gamma rays. The images were taken at an initial time of 
measurement (t = 0 h), t = 1 h 55 min., and t = 4 h. This sequence of images shows the
activity occurring in the field of view as time elapses. The main difference can be seen 
in the cells initially in the center of the field of view.
Figure 6-15. Image Sequence of Actin GFP tagged MCF-7 Sample 6 (Irradiated with 
5 Gy of ̂ Co gamma rays).
Figures 6-16 and 6-17 show a set of three images for the HI GFP tagged MCF-7
sanq)les 4 and 5 respecGvely. Sample 5 was irradiated while sample 4 was not.
Figure 6-16. Image Sequence of HI GFP tagged MCF-7 Sample 4.
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Figure 6-17. Image Sequence of HI GFP tagged MCF-7 Sample 5 (Irradiated with
5 Gy of ^Co gamma rays).
In figure 6-16 the images were acquired at times of 0 h, 1 h 55 min, and 4 h. In the first 
image a brighter nucleus compared to the rest in the field of view is evident It is in the 
process of dividing. In the third and final image the cell has divided and the nuclei of the 
two daughter cells are now approximately the same intensity as the other nuclei visible 
in the field of view. The images in figure 6-17 were acquired at the same time intervals 
of figure 6-16. Once again a brighter nucleus is seen in the initial image and divides as 
time elapses. During the 4 hour period there is also a significant amount of movement 
observed in the field of view representing a general migration to the lower left.
6.2.4. Normalized Fluorescence Spectra (or Actin and HI GFP Tagged 
MCF-7 Cells
The individual raw fiuorescence spectra of Actin GFP tagged MCF-7 cells and 
HI GFP tagged MCF-7 cells were normalized using a ratio of the average area to the 
spectral area confuted using equation 6-2 for each sample. Once normalized, the 
spectra were averaged for each sample. To compare between the Actin GFP tagged 
MCF-7 cell samples (and the HI GFP tagged MCF-7 cell samples separately), the 
average normalized spectra were renormalized with the same method used for the 
absorbance measurements (re. 6.1.2.). Table 6-12 summarizes the normalization 
parameters for the fiuorescence spectra of Actin and HI GFP tagged MCF-7 cell 
samples. Samples 3 ,4 , and 7 for Actin GFP tagged MCF-7 cell and samples 2 ,4 , and 6
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for HI GFP tagged MCF-7 cells were not irradiated. The remaining samples for each 





Ratio of Area to 
Average (All Six Sanq)les) 












4 0.95 1.005 1.08
6 0.88
7 0.85
The normalization ratios in the third column (re. Equation 6-3) were applied to the 
average normalized data to acquire the same renormalized areas to compare the Actin 
GFP tagged MCF-7 cell samples and the HI GFP tagged MCF-7 cell samples 
separately. The variations in the renormalization ratios were 6)und to be consistent for 
all cell samples with no distinction between those non-irradiated and irradiated. The 
ratios of the spectral area for each cell sample to the average spectral area for each cell 
type in the fourth column were determined to be identical due to the renormalization; 
which confirms that the normalization was consistent but was included for consistency 
with the thesis firrmaL
Figure 6-18 and figure 6-19 show the renormalized spectra fin the Actin GFP 
tagged MCF-7 cell samples and for the HI GFP tagged MCF-7 cell samples 
respectively.
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Figure 6-18. Renormalized Spectra of Actin GFP Tagged MCF-7 Cell Samples.
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Figure 6-19. Renormalized Spectra of HI GFP Tagged MCF-7 Cell Samples.
For the Actin GFP tagged MCF-7 cell samples, the renormalized spectra had a 
maximum intensity of approximately 950 counts ± 50 counts. For the HI GFP tagged 
MCF-7 cell samples, the renormalized spectra had a maximum intensity of 
approximately 250 counts ± 50 counts. The small variation in the fluorescence 
intensities indicates little change in the renormalized spectra, which have equal areas 
under curve far each type of tagged cells.
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From the renormalized spectra of living Actin GFP tagged MCF-7 cells in figure 
6-18 the absolute values of the spectral difkrences were calculated with equation 6-6. 
Spectral differences were calculated between samples prepared the same way (i.e. 
irradiated minus irradiated), mid between samples prepared difkrently (i.e. non- 
irradiated minus irradiated). The absolute values of the spectral differences were 
repeated for living HI GFP tagged MCF-7 cells. The intent of this analysis was to 
identify changes in spectral shape not evident from previous ratios of areas.
Equation 6-6. Spectral Difference for Living Cells.
' i L  d im ....
The ratios of the areas of spectral difkrences for the renormalized spectra to the average
area were calculated for the wavelength range of 510 nm to 800 nm and are summarized 
in table 6-13 for Actin GFP tagged MCF-7 cells and in table 6-14 for HI GFP tagged 
MCF-7 cells. Where the average areas were calculated separately for the non-irradiated 
minus non-irradiated (N-N), irradiated minus irradiated (I-I), and non-irradiated minus 
irradiated (N-I).
Sample No.'s Ratio of Area to Average Area of Spectral Difference
3 - 7 0.48
N-N 4 - 7 1.08
3 - 4 1.44
6 - 1 0 0.59
I-I 9 - 1 0 0.98
6 - 9 1.43
7 - 6 0.41
4 - 1 0 0.48
4 - 6 0.72
3 - 6 0.74
N-I 7 - 1 0 0.82
4 - 9 0.98
3 - 1 0 1.06
7 - 9 1.78
3 - 9 2.02
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Table 6-13 shows the ratio of the spectral area to the average area of Actin GFP tagged 
MCF-7 cell samples. For N-N the ratios vary from a minimum of -  52% to a maximum 
of + 44%, for I-I the ratios vary from a minimum of -  41% to a maximum of + 43%, and 
for N-I the ratios vary from a minimum of -  59% to a maximum of + 102%.
Table 6-14. Ratios of the Spectral Difkrence for HI GFP Tagged MCF-7 Cells.
Sample No.'s Ratio of Area to Average Area of Spectral Difference
4 — 6 0.64
N-I 2 - 4 1.17
2 - 6 1.18
3 - 5 0.86
I-I 5 - 7 1.02
3 - 7 1.13
4 - 3 (L61
2 - 5 0.61
6 - 3 0.65
4 - 5 0.76
N-N 6 - 5 0.78
6 - 7 1.25
2 - 3 1.39
2 - 7 1.44
4 - 7 1.51
Table 6-14 shows the ratio of the spectral area to the average area of HI GFP tagged 
MCF-7 cell samples. For samples prepared in the same way the ratios varied from a 
minimum of -  36% to a maximum of + 18% (for N-N and I-I), and for samples prepared 
in different ways (for N-I) the ratios varied from a minimum of -  39% to a maximum of 
+ 51% (re. 7.2. Fluorescence Spectroscopy and Imaging for a discussion of the 
signifrcance of these results).
Appendix Vl.iv. Analysis Summary for Fluorescence Measurements for Living 
Tagged MCF-7 Cells) contains an overview of the raw and normalized fluorescence 
measurements of both Actin and HI GFP tagged MCF-7 cells.
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6.2.5. Raw Fluorescence Measurements for Colon Tissue
Fluorescence measurements were also acquired with the normal and cancerous 
colon tissue samples for patients PA and PB. Two sets of fluorescence spectra and 
images were obtained for each sample, resulting in 48 spectra in total. Raw fluorescence 
spectra of the colon tissue for patient PA and PB are shown in Ggures 6-20 and 6-21 
respectively, for the established wavelength range of 510 nm to 800 nm.
800  PA N  - Spectral Set 1
 PA C  - S pectral Set 1
 P A N  - Spectral Set 2






W aveleng th  (nm)
Figure 6-20. Raw Fluorescence Spectra of Colon Tissue 6om Patient PA 
(Normal -  N and Cancerous — C).
PBN - Spectral Set 1 
PBC - Spectral Set 1 
PB N  - Spectral Set 2 
PBC - Spectral Set 2
O 600
W a w le i^ th  (nm)
p p g g G g ;
Figure 6-21. Raw Fluorescence Spectra of Colon Tissue 6om Patient PB 
(Normal -  N and Cancerous -  C).
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Each spectral set was plotted for the fluorescence spectra of each patient tissue type, 
Wiere N denotes normal and C denotes cancerous colon tissue samples. The maximum  
intensities for patient PA from figure 6-20 varied between 200 counts and 900 counts for 
normal tissue and 100 counts to 800 counts fr»r the cancerous tissue. Similarly the 
maximum intensities fr)r patient PB in frgure 6-21 ranged from 450 counts to 550 counts 
for normal and 400 counts to 1100 counts for cancerous tissue samples. These 
variations in the fluorescence spectra are discussed in section 7.2. Fluorescence 
Spectroscopy and Imaging.
To 6cilitate analysis of these results, the spectral areas were also calculated by 
performing a summation of the spectral intensities for the averaged spectra (re. Equation 
6-1) for the wavelength range of 510 nm to 800 nm. Table 6-15 shows the ratios of the 
spectral areas for each spectral set and tissue type relative to the average area of all 
spectral sets and tissue types for each patient.
Table 6-15. Ratios of Spectral Area for Fluorescence of Colon Tissue.
Spectral
Set Sample
Ratio of Area to Average 










The ratios of the spectral areas for each patient were an alternative means of assessing 
the spectral data. For patient PA this ratio varies between - 74% to + 65%, whereas for 
patient PB this ratio varies between a minimum of - 39% and a maximum of + 77% for 
the normal and cancerous colon tissue samples. For spectral set 1 the ratio of the areas
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to the average area were less than or equal to those for spectral set 2 for patient PA and 
PB.
Fluorescence images of the colon tissue samples were obtained in conjunction 
with each spectrum. Attempts were made to use similar looking areas on each tissue 
type (normal and cancerous) between patients. Figure 6-22 shows four typical 
fluorescence images, two ûom each patient In the fluorescaice images of the normal
tissue (6-22a and 6-22c) definite structure can be seen whereas the cancerous tissue (6- 
22b and 6-22d) structures are not as well defined.
a ) (hi
Figure 6-22. Fluorescence Images of (a) PAN, (b) PAC, (c) PBN, and (d) PBC 
Samples.
6.2.6. Normalized Fluorescence Spectra for Colon Tissue
The individual raw fluorescence spectra of colon tissue were normalized using 
the ratio method of the average area to the spectral area as in equation 6-2. The 
normalized fluorescence s%)ec1ra were calculated for each spectral set Similar to the
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
87
normalized absorbance spectra for colon tissue, the spectral data were interpreted by 
comparing normal to cancerous tissue of the same patient and by comparing patiait to 
patient the same type of tissue, i.e. PAN to PBN, and PAC to PBC (re. 6.1.2).
For the comparison of cancerous to normal tissue for each patioit, tlie spectral 
data \vere renormalized using the same techniques as described fbor absorbance (re. 
6.1.2.). Table 6-16 summarizes the renormalization ratio (re. Equation 6-3) for each 
q)ectral set of patients PA and PB in the third column and the ratio of the spectral area to 
the average area for bodi q)ectral sets and tissue types in the 6)urth column.
Table 6-16. Fluorescence Renormalization Parameters for Colon Tissue.
Spectral
Set
Renormalization Ratio Ratio o f Renormalized Area to
Sample Per Spectral Set 
(re. Equation 6-3)
Average (both Spectral Sets) 
per Patient (re. Equation 6-1)
1 PAN 0.79 0.35PAC 1J7
PAN 1.00
1.652 PAG 1.00
1 PBN 0.88 0.52PBC 1.16
PBN 0.89 1.48z PBC 1.14
Tlie renormalization ratios are usxxl so tfuütbMSSwime areaisare ol%üiuie%lf(Mr<5aclisqpectral 
set to compare between the cancerous and normal colon tissue. For PAN the 
renormalization ratios are less than or eqiml to the normalization ratios 6)r PAC. For 
PBN the renormalization ratios are less than the normalization ratios for PBC. The ratio 
of the average renormalized areas for the fluorescence qiectra of patient PA varied 
between - 65%, and + 65% whereas for patient PB the ratios varied between -  48% and 
+ 48%. As observed for the raw fluorescence, the ratios of the areas were found to be 
less for the Grst spectral set compared to the second spectral set. The renormalized 
fluorescence spectra for patient PA are shown in hguies 6-23 arxi for patient PB are
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shown figure 6-24 for the wavelength range of 510 nm to 800 nm. From 6gure 6-23 the 
renormalized fluorescence spectra for patient PA ranges 6om a maxiimnn peak intensity 
of approximately 150 counts to 850 counts. The renormalized fluorescence spectra 6>r 
patient PB vary between a maximum peak intensity of 450 counts to 1225 counts. The 
maximum peak appeared at 528 nm ± 2 nm 6)r patient PA and at 527 nm ± 1 nm for 
patient PB, i^tere the uncertainty is determined 6om the standard deviatioiL
900
 R enonn PA N  Spectral Set 1
 R enonn PAC Spectral Set 1
 Renorm  PA N  Spectral Set 2 -
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Figure 6-23. Renormalized Fluorescence Spectra to Compare Colon Tissue
Samples of Patient PA.
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 R enonn PBC Spectral Set 1
 Renorm  PBN Spectral Set 2
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Figure 6-24. Renormalized Fluorescence Spectra to Compare Colon Tissue 
Samples of Patient PB.
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The diOerence between the cancerous colon tissue and normal colon tissue 
spectra was calculated for patient PA and for patient PB (re. Equation 6-4). A 
summation was then performed over the spectral difference for the wavelength range of 
510 nm to 800 nm (re. Equation 6-1). Table 6-17 summarizes the ratios of the area of 
the spectral difference to the average spectral difference A)r each spectral set.
Table 6-17. Ratios of the Spectral Difference between Fluorescence Spectra 
of Cancerous and Normal Colon Tissue.
Sample
Difference
Ratio of Area to Average Spectral 
Difference per Patient 
Spectral Set 1
Ratio of Area to Average Spectral 
Difference per Patient 
Spectral Set 2
PAC-PAN 0.74 0.97
PBC - PBN 1.26 1.03
The ratios of the area of spectral differences between the fluorescence spectra of 
cancerous and normal colon tissue for patient PA varied from - 26% for spectral set 1 to 
-  3% for spectral set 2. For patient PB the ratios of the areas of spectral differences 
varied from + 3% for spectral set 2 to + 26% for spectral set 1. The difkrences are 
symmetric about the mean due to the limitation of having only two patients. As already 
mentioned the analysis approach is intended (and more appropriate) for use with 
numbers of patient samples greater than two.
A renormalization of the spectral data was then performed to again facilitate the 
inter-patient comparison of patient PA to patient PB. Table 6-18 summarizes the 
renormalization ratio far each set of spectra far patients PA and PB in the third column 
(re. Equation 6-3) per spectral set and the ratio of the spectral areas to the average 
normalized areas far each tissue type far both spectral sets in the fourth column.
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Table 6-18. Fluorescence Renormalization Parameters for the Inter-patient
Spectral
Set
Renormalization Ratio Ratio of Renormalized Area to
Sample per Spectral Set 
(re. Equation 6-3)
Average Area (both Spectral Sets) 
per Tissue Type
I PAN 1.61 0.49PBN 0.73
PAN 1.35
1.512 PBN 0.79






The renormalization ratios for normal and cancerous colon tissue spectra were used to 
Acilitate inter-patient comparison. As a result the renormalized spectral areas were set to 
be equal for each spectral set and tissue type. The renormalization ratios far both the 
normal and the cancerous colon tissue from patient PA were greater compared to those 
for patient PB. The ratios of the renormalized areas for the normal tissues varied by ± 
51% and for the cancerous tissues were within ± 58%. The renormalized fluorescence 
spectra for the inter-patient comparison for normal colon tissues are shown in frgures 6- 
25 while those for cancerous colon tissue are shown figure 6-26. Again the wavelength 
range was of 510 nm to 800 nm was chosen to display the data. For the interpretation of 
these results refer to the discussion 7.2. Fluorescence Spectroscopy and Imaging.
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Figure 6-25. Renormalized Fluorescence Spectra for the Inter-patient Comparison 
of Normal Colon Tissue.
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Figure 6-26. Renormalized Fluorescence Spectra for the Inter-patient Comparison
of Cancerous Colon Tissue.
For both the renormalized fluorescence spectra for normal and cancerous colon tissue 
spectral set 2 yielded higher intensities relative to spectral set 1 by 24 ± 3% (re. 7.2. 
Fluorescence Spectroscopy and Imaging for a discussion of these results).
The absolute value of the spectral difference was also calculated for the inter­
patient comparison of normal to normal and cancerous to cancerous colon tissue (re. 
Equation 6-5). The spectral difkrence was again summed over the wavelength rar%e of
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510 nm to 800 nm (re. Equation 6-1), and the spectral difkrence for each tissue type 
relative to the average spectral difkrence were calculated for each spectral seL Table 6- 
19 summarizes the ratios of areas between the normal tissue spectra for patients PA and 
PB and the cancerous spectra for patient PA and PB.
Table 6-19. Ratio of Spectral Difkrences by Inter-patient Comparison of
Sample
Difference
Ratio of Area to Average Spectral 
Difference (all six) per Tissue Type 
Spectral Set 1
Ratio of Area to Average Spectra! 




The ratio acquired for the absolute value of the spectral difkrence relative to the average
area of normal colon tissue for the fluorescence spectra had a spread of 0% to -  25% for 
the two spectral sets. For cancerous colon tissue the ratio varied from 0% to + 25% for 
the two spectral sets.
An analysis summary for raw and normalized fluorescence measurements of 
colon tissue has been provided in the appendices (re. Appendix VI.v. Analysis Summary 
for Fluorescence Measurements far Colon Tissue).
7. DISCUSSION
Absorption and fluorescence are the two basic and distinct spectroscopic ^iproaches 
that were exploited as a practical means of distinguishing between biological samples, in 
particular cancerous and normal tissue. Due to the inhomogeneous nature of cells and 
tissues, fluorescence spectroscopy was complemented using imaging techniques that 
permitted clear delineation of the area 6om vhich the spectroscopic information was 
derived.
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7.1. ABSORPTION SPECTROSCOPY
Absorption spectroscopy was investigated using a spectroscopic measurement 
system to characterize the normal and cancerous colon tissue samples at an area on the 
sample. The area of this sample is approximately 1.6 cm^, large in comparison to 
cellular dimensions, but relatively small in terms of the typical volume of organs and 
samples. Optical Gbres with diameters of 400 pm were used to illuminate and collect 
l i^ t  from the samples. The challenges included designing a sample holder to 
accommodate tissue sanq)les mounted onto microscope slides and adjusting the sample 
to examine areas of interest. In general, the tabletop sample holder worked well for the 
preliminary measurements; however there were disadvantages to the design including a 
poor light seal that allowed stray light from external sources to potentially affect 
acquired spectra. The mounts holding the illumination and collection optics were 
difficult to align reproducibly at the same height and proper angle for maximum spectral 
signal.
For the raw absorbance spectra of normal and cancerous colon tissue for patient 
PA and PB, the maximum peak intensities varied between 550 counts to 1900 counts (re. 
Figures 6-1 and 6-2). This variance is attributed to dependencies on the area of the 
sample, variations in the sample set-up, and the time that el^sed  after sample 
preparation. For each sample type, the areas of interest were chosen in a relatively W  
/me manner without a microscope to assist in identi^dng areas based on similarity of 
appearance. Consequently, difkrences in experimental results may also be attributed to 
variations in morphology, which could be useful, and the thickness of the tissues, which 
does not ofkr the type of biological indicator or marker being sought. Tissue samples
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were prepared using a nominal thickness of 10 pm in an efrbrt to enhance the 
contribution of morphology over thickness. The alignment of the tabletop sample holder 
was venfied before each measurement although, as already mentioned, the prototype 
arrangement had limitations in this regard. Furthermore the time of measurement after 
sample preparation may have also aSected the absorbance spectra. Spectral sets 2 and 3 
were measured well after the initial preparation. Absorbance measurements performed 
days after the initial preparation yielded lower intensities. The quality of these samples 
deteriorated with time when stored at room temperature. The results may have remained 
more consistent if the samples had been stored at -  80 *0 in a microscope slide box with 
a desiccant to absorb moisture. Clearly ftiture work should incorporate such strategies 
or, at least, ensure that there is a consistent time frame used for preparation and 
subsequent measurements.
As an alternative to using simple peak heights, the ratio of the spectral areas 
relative to the average area of the raw absorbance corresponding to patients PA and PB 
(re. Table 6-1) were considered a& a means of illustrating the variation in the raw 
absorbance spectra for the normal and cancerous colon tissue. The average deviations 
from the mean of these ratios were 33% fr)r patient PA and 29% for patient PB, 
indicating a consistent spread fr)r the two patients. The ratio method would be more 
practical for studies with a number of patients greater than two. Regardless this method 
was chosen as groundwork frn future comparison studies involving larger groups of 
patients.
To facilitate analysis of variations in spectral characteristics between spectra, the 
raw absorbance spectra were also normalized on the basis of areas. This approach 
minimized the influence of some of the less desirable experimental considerations (re.
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6.1.2). Two separate inter-comparisons were performed on this basis. First, the 
normalized spectra were renormalized to compare between normal and cancerous colon 
tissue spectra from the same patient. A second renormalization was perkrmed to 
compare between the same tissue types from different patients.
When renormalized absorbance spectra obtained from cancerous colon tissue 
were compared to those obtained for normal colon tissue from the same patient, a 
spectral shift was observed. The cancerous colon tissue spectra had a shift of 4 nm ± 2 
nm fr)r patient PA and a shift of 5 nm ± 3 nm for patient PB in the wavelength range of 
450 nm to 550 nm. In the wavelength range of 750 nm to 850 nm the spectral shifts 
were 5 nm ± 3 nm and 8 nm ± 4 nm for patient PA and PB respectively (re. Figures 6-3 
and 6-4). The ratios of the renormalized area to the average area were greater for 
spectral set 1 compared to spectral sets 2 and 3 (re. Table 6-2), consistent with the raw 
absorbance spectra. The effect can be attributed to factors already identified. The 
absolute value of the spectral difference between cancerous and normal colon tissue 
spectra for all three renormalized spectral sets demonstrated two distinct peaks for both 
patient PA and patient PB. These peaks arise as a result of the offret between the 
cancerous and normal colon tissue spectra. The largest spectral difkrences were 
observed at two inflection points near 530 nm ± 10 nm and 780 nm ± 10 nm wbile that 
near 640 nm showed the smallest difkrences (re. Figure 6-5). As suggested by the 
general shape of the spectral differences curves, a multiple peak Gaussian frt was 
applied. The Gaussian frts conformed well with the spectral differences except in the 
region between the peaks wfrere the smallest difference existed (near 640 nm ± 10 nm). 
The Gaussian frt was useful in providing quasi-parameterizations. Le. the peak 
maximum and the full width half maximum (FWHM), that facilitate inter-comparison
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between cancerous and normal tissue from the same patient (re. Table 6-3). In these 
spectra there were two prominent peaks. For patient PA the peak maxima were located 
at 532 nm and 770 nm, with respective FWHM of 95 nm and 149 nm. For patient PB 
the peak maxima were located at 538 nm and at 785 nm, with respective FWHM of 100 
nm and 155 nm. The difrerences between the peak maxima indicates a spectral shifr, 
^&hereas difrerences between the FWHM are indicative of changes in the line s h ^ .  
The spectral differences as determined by calculating the area under the curves 
(including the signs) were essentially zero, indicating that the observed difrerences were 
simply a result in a shifr of the spectrum rather than an actual change in the 
characteristics or shape. For the spectral difrerence between normal and cancerous 
colon tissue, the spread of the spectral areas relative to the average area was 22% for 
both patients PA and PB (re. Table 6-4). The Gaussian fit parameters and the ratio (area 
of spectral difference to average area) suggests a potential means for distinguishing 
between cancerous and normal tissue types, and warrants further investigation.
The comparison of the same tissue types from difkrent patients yielded 
renormalized spectra with a similar shape but without a spectral shifr (re. Figures 6-6 
and 6-7). The ratios of the renormalized area relative to the average area for the inter­
patient comparison (re. Table 6-5) were greater k r  the frrst spectral set compared to the 
later two spectral sets, and again this difrerence is attributed to reasons previously 
mentioned. The spectral difkrence between patients PA and PB resulted in a curve 
similar to the comparison of tissue frmn the same patient, but with less than half the 
intensity (re. Figure 6-8). The Gaussian frts conformed well to the spectral difkrences 
showing the general sh^)e excluding the noise. Two main peaks were observed, with 
the maximum peak positions and the full width half maximum (FWHM) values obtained
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for the Gaussian frt (re. Table 6-6). The average peak maximum for normal colon tissue 
had the frrst peak at 542 nm and the second peak at 803 nm, with respective FWHM of 
158 nm and 229 nm. The average peak maxima of the two peaks were 541 nm and 795 
nm respectively with widths of 120 nm and 189 nm for cancerous colon tissue. The 
maximum peak positions were similar for both the normal and cancerous colon tissue 
\^hereas the FWHM values for the two peaks were greater for cancerous compared to 
normal colon tissue. For the spectral difference between normal and cancerous colon 
tissue, the spread of the spectral areas relative to the average area was 41% for both 
patients PA and PB (re. Table 6-7). These variations in the average deviation from the 
mean being essentially the same make it difficult to use these data to reliably 
differentiate between the tissue types. Although, the full width half maximum values 
obtained from the Gaussian fit could potentially be an indicator to differentiate between 
tissue types.
For the comparison of the difkrent tissue types from the same patient, a spectral 
shifr was observed in contrast to no ^xparent shifr k r  the comparison of the same tissue 
types from different patients. The ratios of the spectral differences relative k  the average 
spectral difference k r  the same patient comparison of colon tissue had a lower average 
deviation compared k  those derived from the comparison of the colon tissue for the 
inter-patient. The spectral shifr, the ratios of the spectral difkrences and the maximum 
peak position from the Gaussian frt suggest that, using absorbance spectroscopy, the 
same patient comparison can be a potential method k  distinguish between normal and 
cancerous colon tissue. However, the full width half maximum from the Gaussian frt 
which were similar k r  difkrent tissue types from the same patient, varied k r  the same
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tissue type from different patients, suggesting that, the inter-patient comparison can be a 
potential means of distinguishing between tissue types.
7.2. FLUORESCENCE SPECTROSCOPY AND IMAGING
After examining several possible arrangements, the final fluorescence system 
included a combined imaging and spectroscopic measurement system that allowed for 
subjective localization of the area of interest to be examined. Fluorescence 
measurements were conducted with normal and cancerous colon tissue, ethidium 
bromide, frxed tagged cells, and living tagged breast cancer cells. The spectroscopic 
measurement system for fluorescence incorporated illumination through an epi- 
fluorescence microscope, and collection through an adapter designed to couple the 
emitted light from the eyepiece into a 400 pm diameter fibre connected to the 
spectrometer. The disadvantage was that only a portion of the fluorescence emission 
could be collected by the spectrometer due to limitations of the adapter and fibre.
As expected, the raw fluorescence spectra of EtBr decreased in intensity as the 
concentration of EtBr was decreased. With an emission wavelength range of 510 nm to 
800 nm, EtBr was used as the reference standard (re. 4.1. Reference Standards). The 
spectral area under the curve also shows a decrease with concentration (re. Figure 6-9). 
The spectral areas of the EtBr concentrations (0.1 pg/ml to 50 pg/mi) to the wavelength 
had a non-linear response. For the 0.1 pg/ml concentration of EtBr, the spectra were 
essentially noise fluctuations with spectral areas of -1000 counts ± 2000 counts (re. 
Table 6-8). This last result indicates the lower limit on concentration that is detectable 
with this system and the associated measurement parameters. If system refinements
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were introduced to reduce the signal to noise ratio it is most likely that the lower limit of 
detection could be extended.
Fluorescence measurements of the fixed tagged reference cells were used to align 
the eyepiece/fibre adapter and to set the microscopes iris size to collimate the area finm 
which the optical fibre could actually collect light. The disadvantage was that the iris 
size was established based on centering the fixed tagged cells in the field of view for 
each measurement, introducing the likelihood of deviations jfrom set-up to set-up. In an 
effort to ensure consistencies in the iris size, both the spectra and the images acquired 
during the initial alignment of the adtqiter were compared to the spectra and images of 
reference cell sample bekre acquiring measurements k r  each sample. The raw 
fluorescence spectra for the fixed tagged cells taken with both the 40 x and 60 x 
objective magnifications for the minimum and optimum iris sizes had maximum peak 
intensities at approximately 555 nm ± 5 nm (re. Figure 6-10). The average spectral areas 
j&om the 13 spectra of the fixed tagged cells k r  each configuration had an uncertainty of 
± 1000 counts (re. Table 6-9). Using the details that could be seen in the fluorescence 
images of the cells, the iris size and center the area of interest in the field of view were 
both ac^usted (re. Figure 6-11).
For the irradiated and non-irradiated Actin GFP tagged MCF-7 cell sangles, the 
raw fluorescence spectra showed a variation in the maximum peak intensities (re. Figure 
6-12). The variations in the peak intensities may be due k  both the sampling area and 
the instrumentation set-ig. The sampling areas k r  each may have had a varying number 
of cells present in the field of view yielding different fluorescence intensities. The 
eyepiece/fibre ad^ter and iris size were verified using the fixed tagged cells bekre each 
measurement as previously discussed, but clearly this approach introduces some
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uncertainties. For the irradiated living cells it would be unlikely to see immediate 
changes due to radiation damage (re. 2.5.). The DNA would be the critical target and the 
damage to the backbone would not be evident until after a single cell division or more. 
As expected, the general sh^x and the maximum peak intensity about 536 nm ± 5 nm 
were consistent for both the irradiated and non-irradiated cells. The ratio of the spectral 
area relative to the average area had an average deviation of 19% (re. Table 6-11) 
indicating consistencies in the spectra. The bright cytoplasm from the Actin GFP 
tagging surrounding the dark nuclei was observed in the fluorescence images (re. 
Figures 6-14 and 6-15). The cells focused in the freld of view were observed to change 
and move with time. Similar activity was observed with both irradiated and non- 
irradiated cell samples.
As with the Actin GFP tagged MCF-7 cells samples, the average raw 
fluorescence spectra of the HI GFP tagged MCF-7 cell samples vary in maximum 
intensity from sample to sample k r  both the non-irradiated and irradiated samples (re. 
Figure 6-13). A peak not apparent with the Actin GFP tagged MCF-7 cells appeared 
near 626 nm ± 5 nm k r  the HI GFP tagged MCF-7 cells. It is possible that this peak 
may be a result of the presence of porphyrins (re. Table 2-2). The average deviation 
from the mean of 14% was determined for the spectral areas relative k  the average area 
(re. Table 6-11) showing consistencies in the spectra. Images acquired using HI GFP 
tagged MCF-7 cells clearly show fluorescence from the GFP fagging of the cells' nuclei 
(re. Figures 6-16 and 6-17). Over time some of the nuclei were observed passing 
through mitosis regardless of whether the cells were irradiated and non-irradiated. The 
nuclei undergoing m iksis ^)pear k  have increased fluorescence intensity in the early 
stages (pophase and metaphase). In prophase the chromosomes have replicated and in
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metaphase the chromosomes are aligned at the mid-plane of the cell. During anaphase 
and telephase, the replicated chromosomes separated and are pulled to the poles as the 
nuclear membrane redevelops. No affect attributable to the radiation exposure was 
observed during the four hour period when measurements were performed.
For renormalized fluorescence spectra, the ratio of the area of spectral difference 
of Actin GFP tagged MCF-7 cell samples had an average deviation from the mean of 
35% for N-N, 29% for I-I and 41% for N-I (re. Table 6-13). The ratio of areas of 
spectral differences of HI GFP tagged MCF-7 cell samples had an average deviation 
from the mean of 24% for N-N, 10% for I-I and 35% for N-I (re. Table 6-14), indicating 
some similarities between non-irradiated and irradiated cells.
The raw fluorescence spectra for the colon tissue samples for the two patients 
(re. Figures 6-20 and 6-21) varied due to the time delay between spectral set 
measurements, alignment of the eyepiece/fibre adapter, and tissue morphology of the 
area of interest (re. 7.1). The areas of interest were based iqx)n subjective similarity of 
appearance as observed through the microscope. The spread in the spectral areas 
relative to the average area had average deviations about the mean from the combination 
of both available spectral sets of 65% and 39% for the colon tissue for patients PA and 
PB respectively (re. Table 6-15). The ratios of the spectral areas were an alternative 
means of illustrating the variation in the raw fluorescence spectra. Fluorescence images 
were shown far a small area of interest on four samples (re. Figure 6-22). The brighter 
regions show the auto-fluorescence from the fluorophores present in the tissues. A large 
number of fluorophores have excitation maxima in the UV and emission in the UV/VIS. 
As a consequence it is difficult to identify components of tissue that are fluorescing with 
the filter cube used in the system with an excitation of 420 run to 490 run and emission
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greater than 520 nm. The fluorescence detected is probably a combination of 
fluorophores. An improvement could potentially be observed by using a better matching 
filter cube such as alternative filter cube a UV-2A filter from Nikon Instruments Inc. 
with an excitation in the 330 nm to 380 nm and an emission above 420 nm. Such an 
alternative filter should enhance detection of fluorophores such as NADH, NADPH, 
certain vitamins and lipids (re. to Table 2-2 for excitation and emission maxima).
The fluorescence qiectra for colon tissue were renormalized (a) to compare 
normal to cancerous colon tissue firom the same patient, and (b) to compare the same 
tissue type (i.e. normal to normal, and cancerous to cancerous) from difierent patients.
The fluorescence spectra comparing different tissue types from the same patient 
had a maximum peak intensities positioned at approximately 528 nm ± 2 run for patient 
PA and 527 nm ± 1 run for patient PB. The ratios of the spectral differences for each 
spectral set had an average deviation from the mean of 15% for both patient PA and PB 
(re. Table 6-17). In general, the sample difkrences were found to be greater for patient 
PB compared to patient PA.
The inter-patient comparison revealed large discrepancies between the 
renormalized areas for both the normal and cancerous colon tissue. Spectral set 2 was 
24 ± 3% higher than spectral set 1, which may be attributed to the time elapse between 
measurements (re. Figures 6-25 and 6-26). The ratios of the spectral difrerences had an 
average deviation of 13% for both normal and cancerous tissues (re. Table 6-19). In 
general, the sample difkrences for cancerous colon tissues were found to be greater than 
or equal to that for normal colon tissue.
In contrast to the absorption spectroscopy of colon tissue (22% for same patient 
and 41% for inter-patient comparison), the ratio of the spectral difrerences relative to the
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average spectral difrerence for the fluorescence spectra of the same patient comparison 
and the inter-patient comparison were both low (15% and 13% respectively). The 
difference in the results obtained for the same patient comparison may be attributed to 
the fact that the cancerous colon tissue from patient PA is a moderately difkrentiated 
adenocarcinoma while that for patient PB is moderately difrerentiated invasive 
adenocarcinoma. The same-patient comparison and the inter-patient comparison may be 
potential methods to distinguish tissues; however, further investigations are required.
8. CONCLUSION
The instrumentation and measurements for absorbance and fluorescence 
presented offer a preliminary groundwork for further investigation into the potential of 
optical spectroscopy to provide non-invasive diagnostic techniques for cancer detection.
The tabletop microscope slide holder for absorption spectroscopy worked well 
for the preliminary measurements. An ideal system for absorption would be a combined 
imaging - spectroscopic measinement system such that an area of interest could be more 
readily localized. The microscope, eyepiece/frbre adapter, and CCD camera used for the 
fluorescence measurements could potentially be modified so that excitation could 
originate fi"om underneath the microscope stage (i.e. from an optical fibre coiq)led to a 
light source). Alignment of the fibre with the objective, matching the excitation and 
collection areas, and the use of filters are a few of the challenges that would have to be 
addressed.
The normalization of the absorbance spectra to compare cancerous to normal 
colon tissue from the same patient for the wavelength range of 450 nm to 550 nm 
showed a spectral shifr of 4 nm ± 2 nm and 5 nm ± 3 nm k r  patient PA and PB
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respectively; and k r  the wavelength range of 750 nm to 850 nm showed a spectral shift 
of 5 nm ± 3 nm and 8 nm ± 4 nm k r  patient PA and PB respectively. The spectral shift 
suggests differences in the morphology and absorption properties of the colon tissues. 
The spectral difference relative to the average spectral difrerence k r  the same patient 
comparison had a lower average deviation from the mean compared to the inter-patient 
comparison indicating a potential method in identi^dng between normal and cancerous 
tissues. The Gaussian frt k  the spectral difrerence curves provided fitting parameters 
that could be useful. For the same patient comparison the maximum peak and full width 
half maximum (FWHM) were kund k  be similar between the two patients, although k r  
the inter-patient comparison there was a significant difference in the FWHM. The 
differences in the FWHM may indicate a potential method to identify different tissue 
types. For absorption spectroscopy, the framework of analysis for same patient and the 
inter-patient comparisons have been established. However, more samples from a number 
of patients are needed k  verify whether or not these observations are consistent.
The EtBr concentrations served as fluorescence reference standards k r  the 
fluorescence system, wbere the 0.1 pg/ml concentration of EtBr was determined k  be a 
limiting concentration k r  the system. The fluorescence instrumentation, including the 
microscope, eyepiece/fibre adqrter, and CCD camera, allowed k r  the acquisition of 
spectra and the corresponding image of the sample k r  use in localizing the areas of 
interest. The fixed reference cells were used with moderate success k  set the iris size k r  
the adapter with the 20 x magnification objective and the 400 pm diameter fibre. 
Development of a more systematic approach k  adjusting the iris size and adapter 
geometry would be advantageous.
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The GFP tagged living cell samples were used to investigate a known 
fluorescence signal with a high intensity before moving onto less intense untagged cell 
samples. Untagged samples permit the study of endogenous rather than exogenous 
fluorophores. The fiuorescence imaging with the HI GFP tagged MCF-7 cell samples 
illustrated various stages of cell division (mitosis) and cellular movement regardless of 
whether the or not cells were irradiated. Although mitosis was not observed with Actin 
tagged MCF-7 cell samples, cellular movement was evident. The normalization of 
irradiated cell sample spectra investigation revealed, for the time frame of the 
measurements, no affects which could be attributed to radiation exposure. The spectra 
from the HI GFP tagged MCF-7 cell samples had a small peak centered at 626 nm ± 5 
nm which was not apparent in the spectra from the Actin GFP tagged MCF-7 cell 
samples. That peak could potentially be attributed to the presence of porphyrins. Future 
work with the living cell samples could be done by acquiring spectra at different times 
after irradiation (i.e. days) or by comparing non-irradiated, irradiated, and dead cells to 
investigate apoptosis. These measurements could be performed with either tagged or 
untagged living cells. The problem with imtagged cells is that the fluorescence intensity 
is lower in comparison to tagged cells, and the fluorescence intensity decreases (photo­
bleaches) at a faster rate than tagged cells.
Fluorescence measurements of colon tissue yielded similar average deviations of 
the spectral difrerences for (a) same patient (cancerous to normal) comparisons and (b) 
inter-patient (normal to normal and cancerous to cancerous). More samples and other 
excitation wavelength ranges would be required to establish whether or not any 
significant clinical information can be reliably obtained. To examine endogenous 
fluorophores, it would be more practical to excite in the UV wavelength range for
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spectral characteristics of known fluorophores as shown by Alfano et a/. (1987), 
Schomacker (1992a, 1992b), and Majumber ef a/.(1999).
The cancerous and normal colon tissue, Actin and HI GFP tagged MCF-7 cells, 
five EtBr concentrations, and fixed reference cells, were used to study optical 
spectroscopy techniques. Further spectroscopic investigations of normal and cancerous 
tissues and cell samples are needed to draw any definitive conclusions regarding the 
potential for developing non-invasive diagnostic techniques; however, the present work 
clearly establishes the potential k r  ultimate development of such techniques and the 
groundwork that will enable these future investigations.
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Change in Energy of a Molecule 
Patent Reflectance 
Iodine -125  
Cesium -137  
Iridium -198 
8- aminolevulinic acid 
Cobalt - 60 
Absorbance Reading 
Half Cone Angle 
Anolog to Digital 
Argon/Krypton Mix 
Borosilicate crown 
Breast Self Examination 
Speed of Light in Vacuum 
Cancerous Tissue 
Clinical Breast Examination 
Charged Coupled Device 
Intermediate Concentration of E a r  
Carbon Dioxide 
Computer Tomography 
Target Concentration o f E a r  
Dark Intensity Reading 
Double Contrast Barium Enima 






Deflection (Scattering) Angle 
Field Size 
Flavin Adenine Dinucleotide 
Fetal Bovine Serum 
Fecal Occult Blood Tests 
Field of View 
Full Width Half Maximum 
Green Fluorescent Protein 
Grating Spectral Range 





Energy o f a scattering {dioton








MOS Metal Oxide Semiconductor
n Index of Re&action
N Normal Tissue
N-I Non-irradiated Cell Sample Spectrum minus Irradiated Cell Sample Spectrum
N-N Non-irradiated Cell Sample Spectrum minus Non-irradiated Cell Sample Spectrum
ni Index of Refraction of Incident Medium
02 Index of Refraction o f Tissue
NA Numerical Aperture
N* Number of Photons Absorbed
NADH Reduced Nicotinamide Adenine Dinucleotide
NADPH Reduced Nicotinamide Adenine Dinucleotide Phosphate







PAC Cancerous Colon Tissue Samples from Patient A
PAN Normal Colon Tissue Samples from Patient A
PB Patient B
PBC Cancerous Colon Tissue Samples from Patient B
PBN Normal Colon Tissue Samples from Patient B
PDT Photodynamic Therapy
PpIX Protoporphyrin IX
PVC Poly Vinyl Chloride
R Reference Intensity Reading
S Sample Intensity Reading
0 Standard Deviation
So Singlet Ground State
Si Singlet Excited State
S2 Singlet Excited State
SAD Source to Axis Distance
SiOz Silicon Dioxide




V Speed of Light in a Medimn
Vo Ground State Vibratitmal Energy Level
Vi Elevated Vikational Biergy Level
V2 Elevated Vibrational Enagy Level
V. A^ilied Voltage
VEtBr Volume of EtBr
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Abbreviation Full Name
V h20 V olume of W ater
VIS Visible
V„ Vibrational Energy Level
Vt Total Volume (EtBr plus Ĥ O)
e Angle of Incidents
8' Angle o f Reflection
8" Angle of Refraction
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APPENDIX n  
UNIT CONVERSIONS
Units Full Name Conversion Description
cm̂ Centimetres Squared 1 cm^= Ix 10"* m̂ Area
pg/ml Microgram p a  millilitre 1 pg/ml = 1x10"® kg/1 Concentration
nm/pixel Nanometre per Pixel Dispersion
cGy Centi Gray 1 cGy = 0.01 Gy = 0.01 J/kg Dose
Gy Gray 1 Gy = 1 J/kg Dose
eV Electron Volt leV  = 1.602xl(F"j Energy
keV Kilo Electron Volt 1 keV - 1x10̂  eV Energy
MeV Mega Electron Volt 1 M eV - 1x10  ̂eV Energy
Hz Hertz 1 Hertz = 1 cycle/second Frequency
cm Centimetres 100 cm = 1 m Length
mm Millimetre 1 mm = 0.001 m Length
nm Nanometre 1 nm= 1x10"® m Length
pm Micrometre 1 pm= lxlO"*m Length
M Molar 1 mole substance/1 L solution Molarity
mM MilliMolar 1 mM = 0.001 M Molarity
W Watts 1 W = IJ/s Power
Q Ohms 1 n  = IV/A Resistance
K Kelvin K -°C  + 273.15 Temperature
=C Degrees Celsius Temperature
min Minutes 1 min = 60 s Time
ns Nanosecond 1 ns= 1x10"® s Time
s Seconds Time
hr Hour 1 h = 3600s Time
m/s Metre per Second 1 m/s Velocity
V Volts 1 V = IJ/C Voltage
ml Millilitre 1 ml = 0.0011 Volume
pi Microlitre 1 pi =1x10^1 Volume
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APPENDIX m  
PRODUCTS
Product No. Name Company
46047 Ethidium Bromide Sigma-Aldrich Co.
430165 Polystyrene Cell Culture Dishes Crnning
48380068 Micro Cover Glass 22 mm No. 1 VWRIntematimial
11835-030 Gibco RPMI Medium 1640 Gibco
15249-062 Antibiotic-Antimycotic Gibco
74-UV Collimating Lens Ocean Optics, Inc.
74-VIS Collimating Lens Ocean Optics, Inc.
B-3A Filter Cube Nikon Instruments, Inc.
Eclipse E400 Epi-fluorescence microscope Nikon Instruments, Inc.
HTB-22 MCF-7 Breast Adenocarcinoma Cell Line American Type Culture Collection
KX32ME Cooled CCD Camera Apogee Instruments, Inc.
L2 Detector Collimating Lens Ocean Optics, Inc.
Leica CM 
1850 Cryostat Meyer Instruments, Inc.
LMIXY X and Y Translating Lens Mount (+/-1 mm) ThorLabs, Inc.
LS-1 Tungsten Halogen Light Source Ocean Optics, Inc.
OFLV Variable Long Pass Order Sorting Filter Ocean Optics, Inc.
S7810 Imaging Spacer Sigma-Aldrich Co.
SM1A2 1 " Tube to 2" Tube Adapter ThorLabs, Inc.
SM1A3 Microscope Objective to 1" Tube Adapter ThorLabs, Inc.
SM1L03 1" Tube 1/3" Deep ThorLabs, Inc.
SM1L05 1" Tube 1/2" Deep ThorLabs, Inc.
SMISMA SMA Fiber Adapter ThorLabs, Inc.
SM1V05 1" Tube Rotating Adjustment Focus 1/2" Travel ThorLabs, Inc.
SM2L05 2" Tube Lens Tube 1/2" Deep ThorLabs, Inc.
SM2V10 2" Tube Rotation Adjustment Focus 1" Travel ThorLabs, Inc.
1LX511 2048 Element CCD Array Sony Electronics, Inc.
USB2000 Minature Fiber Optic Spectrometer Ocean Optics, Inc.
Company Contact Information:
American Type Culture Collection 
P.O. Box 1549 





Auburn, CA 95603 
Phone: (530) 888-0500 
http://www.ccd.com







2270 Industrial SL 




1304 Langham Creek, Suite 235 




1300 Walt Whitman Rd.





Dunedin, FL 34698 
Phone: (727) 733-2447 
http://www.OceanOptics.com
Sigma-Aldrich Co.
2149 Winston Park Dr.
Oakville, ON L6H6J8 
Phone: (800) 565-1400
http://www.sigmaaldrich.com/
Sony Electronics, Inc 
3300 Zanker Rd.




435 Route 206 North 
Newton, NJ 07860 
Phone: (973) 579-7227 
httpV/www.thorlabs.com
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VWR International 
1310 Goshen Parkway 
West Chester, PA 19380 
Phone: (800) 932-5000
http://www.vwr.com





NWORCC D^ertmemt of Medical Phyaice 
Patient Done Calculation (v.6.4) 2003-Aug-20
Patient nueber: OOOOOIC 
Patient name: Actin GPP MCP-7
Date o f calculation: 2003-Aug-20 
Machine: Cl
Total doee of SOOcGy preacribed at 100.0%.
Field Nueber: 1
Field Deecriptioo: le t  1 brs
Energy: 1.2SMeV
Col. Field (XxY): 10.0 X 10.0






Field Daily Doee: 500.0
No. of Fractions : 1
Col. Eq. Square: 10.00
Ref. Eq. Square : 10.00
Unit Dose Rate: 98.0







Beam Dose Rate: 138.8
Timer error (min): -0.01
Time (min): 3.59
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Page l / l
rmvKVk weyaiLWMiL wt neuicai vnyeice 
Patient Doee Calculation (v.6.4) 2003-Jun-26
Patient number: OOOOOIC 
Patient name: HI GPP NCF? Celle
Date of calculation: 2003-Jun-26 
Machine: Cl
Total doee of SOOcGy prescribed at 100.0%.
Field Number: 1
Field Description: le t  1 brs
Energy: 1.25MeV
Col. Field (XxY): 1 0 .0  X 1 0 .0





Field Weighting: 1 .000
Field Daily Dose: 500.0
No. of Fractions: 1
Col. Eq. Square: 10.00
Ref. Eq. Square: 10 .00
Unit Dose Rate: 100.0
Rel. Dose Factor: 1.000
Inv. Sq./Standoff: 1.000
T.P.R.: 1.416
Hedge Factor: 1 .000
Tray Factor; 1 .000
Compensator Factor: 1 .000
Accessory Factor: 1 .000
Beam Dose Rate: 141.5
Timer error (min) : -0 .0 1
Time (min): 3.52




Absorption Measurements of Colon Tissue




(Instrumentation Shut Down) 
1 h 10 min.
1 b 40 min.
Finished
0 h 40 min.
Acquisition o f Spectra 
(Set Measurement Parameters)
Fluorescence Measurements of Living GFP Tagged MCF-7 Breast Cancer Cell Line 
Samples Non-irradiated or Irradiated [5 Gy].
Preparation for Measurements Acquisition of Images/Spectra
(Instrumentation Start Up) (Focused Sample in fov, Set Measurement Parameters)








[Irradiated with 5 Gy of “ Co Gamma Rays] 
Cell Incubator Connected 
to Voltmeter (5 V)
Finished
7b
6 h 30 min.
Completed Measurements 
(Instrumentation Shut Down)
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Fluorescence Measurements of Colon Tissue
Preparation for Measurements 
(Instrumentation Start Up)
Oh
Acquisition of Images/Spectra 
(Focused Sample in fbv, Set Measuranent Parameters) 
1 h 10 min.
Finished 
2 h 10 mih.
1 h 40 min.
Completed Measurements 
(Instrumentation Shut Down) 
0 h 40 min.
Reference Measurements 
(Fixed Tagged Cells)
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APPENDIX VI L
ANALYSIS SUMMARY FOR ABSORPTION
SPECTROSCOPY FOR COLON TISSUE
Absorption Spectroscopy for Colon Tissue. 






Three sets of flumescence spectra and images were acquired for each of die
normal and cancerous colon tissue samples from the two patients. Figures 6-1 





Equation 6-1. (re. page 57) 
bpectral Area -
5.'2C.-., _ ______ _...A
S(k) is the intensity for the given wavelength range of 350 nm to 1000 nm. 
The spectral area was calculated as an alternative method to investigate the 
spectra.
Ratio o f Area to 
Average Area
In Table 6-1 columns 3 and 5 show the ratios of the spectral area (equation 6- 
1) over the average spectral area for all spectral sets for each tissue type and 
patient. The spectral areas are calculated from the raw absorbance spectra in 






Equation 6-2. (re. page 58)
S(k) is the raw spectral reading for a given wavelength, the spectral area is 
calculated using equation 6-1, and the average area is calculated from the 
spectral areas obtained from each spectrum in a given spectral set.
Normalization was carried out to obtain the same area under the curve for a 







Equation 6-3. (re. page 59)
R on orm u lu e^ N l =  A v e r a g e N lx ; ------------ -------------------------------- 1
1 A verage Norraonr'alzed Are. /
Term in the brackets is the renormalization ratio used to acquire the same
spectral areas.
Renormalization was carried out to facilitate comparison between (a) 
cancerous to normal colon tissue from the same patient, and (b) inter-patient 
comparison for the same colon tissue types (i.e. normal to normal and 
cancaous to cancerous). The raiormalized spectra for padmts PA and PB are 
ilhislrated in figures 6-3 and 6-4 respectively Bar the same patient comparison. 
The renormalized spectra for the inter-patient comparison are illustrated in 
figures 6-6 and 6-7.
Ratio of 
Renonnalized 
Area to Average 
Area
In Table 6-2 column 4 Aows the ratios of die renonnalized spectral area 
(equation 6-1) over the average rmormalized qiectral area fry all spectral sets 
frrreachpatiaiL The spectral areas are calculated from the renormalized 
spectra in figure 6-3 and figure 6-4. hr Table 6-5 column 4 shows the rados of 
the renormalized spectral area (equation 6-1) over the average renonnalized 
spectral area fix all spectral sets fix each tissue type. The spectral areas are 
calculated from the rencxmalized spectra in figure 6-6 and figure 6-7.







Equation 6-4. Same patient Conqiarison (re. page 62)
.-aiDtticrentx -  Rcromiql'zedC -  vzif ji ;ÎMi
jjat or 6-> ntc-natient Comparison (re. page 67)
Spcctra!Difference = [Rciiomializt;drA-Rcno' 'iun' d P |
The absolute values of the spectral differences were calculated for the two 
inter-comparisons to investigate variations between spectra. The spectral 
differences were plotted versus wavelength and a Gaussian fit was applied 
from the shape of the curves. For the same patient comparison the spectral 
difference is plotted in figure 6-5 and the Gaussian fit parameters are in table 
6-3. For the inter-patient compa rison the spectral difference is plotted in 
figure 6-8 and the Gaussian fit parameters are in table 6-6. The errors for the 
spectral differences are calculated to the standard deviation (or root mean 
square).
X):
Where o is the standard deviation, N is number o f data points, Xj is a given 
difference and X is the mean difference.




Table 6-4 summarizes the ratio of the spectral area (Equation 6-1) of the 
spectral difference (Equation 6-4) to the average spectral difference for each 
spectral set for the same patient comparison.
Table 6-7 summarizes the ratio of the spectral area (Equation 6-1) of the 
spectral difference (Equation 6-5) to the average spectral difference for each 
spectral set for the inter-patient comparison.____________________________
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APPENDIX VI.iL
ANALYSIS SUMMARY FOR FLUORESCENCE
SPECTROSCOPY FOR ETHIDIUM BROMIDE
Fluorescence Spectroscopy for Ethidium Bromide (EtBr) 





Fluorescence spectra were acquired for 5 concentrations of Ethidium Bromide 
(EtBr). EtBr was used due to its well known spectra, stability, and was readily





Equation 6-1. (re page 57)
Spectral Area
S(k) is the intensity for the given wavelength range o f 510 nm to 800 nm.
An alternative method to investigate the spectra. Table 6-8 summarizes the 
spectral area (Equation 6-1) for each EtBr concentration.
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APPENDIX VliiL 
ANALYSIS SUMMARY FOR FLUORESCENCE 
MEASUREMENTS FOR FIXED TAGGED 
REFERENCE CELLS
Fluorescence Spectroscopy and Imaging for Fixed Tagged Reference Cells 







Raw fluorescence spectra and images were acquired for the fixed tagged 
reference cells initially to align the eyepiece/fibre adapter, adjust the iris size 
to approximate the collection area of the fibre. Before fluorescence 
measurements of colon tissue and living cells the reference cells were used to 
adjust the iris size comparing the images and spectra to the initial results 
during adapter alignment. The raw fluorescence spectra are illustrated in 




Equation 6-1. (re. nage 57)
Spcf irai Area - ]
S(l) is the intensity for the given wavelength range o f 510 nm to 800 nm.
The spectral areas (re. table 6-9) were calculated as an alternative method to 
investigate the spectra.
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APPENDIX V liv. 
ANALYSIS SUMMARY FOR FLUORESCENCE 
MEASUREMENTS FOR LIVING TAGGED MCF-7 
CELLS
Fluorescence Spectroscopy and Imaging for Living Actin and HI GFP Tagged MCF-7 Cells 







Raw fluorescence spectra and images were acquired at 5 minute intervals for 
non-irradiated and irradiated living actin and HI GFP tagged MCF-7 cells. 
The raw fluorescence spectra for actin GFP tagged MCF-7 cells were plotted 
in figure 6-12 and the raw fluorescence spectra for HI GFP tagged MCF-7 




Equation 6-1. (re. page 57)
|>pcccral Area -  ^ S ( \ s
S(l) is the intensity for the given wavelength range of 510 nm to 800 nm.
The spectral area was calculated as an alternative method to investigate the 
spectra.
Ratio of Area to 
Average Area
In Table 6-11 column 4 show the ratios of the spectral area (equation 6-1) over 
the average spectral area for each cell type. The spectral areas are calculated 






Equation 6-3. (re. page 59)
Reromali.redNÎ -  Averairt.N] X ■ Average Area |l
AveraaeNormormali'ed Area |  -, . . . .
Renormalization was carried out to compare between (a) the actin GFP tagged 
MCF-7 cells and (b) the HI GFP tagged MCF-7 cells. The renormalized 




Area to Average 
Area
In Table 6-12 column 4 shows the ratios of the renormalized spectral area 
(equation 6-1) over the average renormalized spectral area for each cell type. 







Equation 6-6. (re. page 82)
Spectral Difivrente - 1 S(L ̂  - R cnofr- V I J
The spectral differences were calculated between N-N, I-I, and N-I. Where 
Non-irradiated (N), and Irradiated (I).




Table 6-13 summarizes the ratio of the spectral area (Equation 6-1) of the
spectral difference (Equation 6-6) to the average spectral difference for N-N, 
I-I, and N-I.
Table 6-14 summarizes the ratio of the spectral area (Equation 6-1) of the 
spectral difkrence (Equation 6-6) to the average spectral difkrmce fix N-N, 
I-I, and N-I.
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APPENDIX VIv.
ANALYSIS SUMMARY FOR FLUORESCENCE
MEASUREMENTS FOR COLON TISSUE
Fluorescence Spectroscopy and Imaging for Colon Tissue 







Two sets of fluorescence spectra and images were acquired for each of the 
normal and cancerous colon tissue samples from the two patients. Figures 6-20 





Fcuat'cr  ̂ 1 (*•? page'̂ 7) 
Spectral Area =
S(l) is the intensity for the given wavelength range o f 510 nm to 800 nm.
The spectral area was calculated as an alternative method to investigate the 
spectra.
Ratio of Area to 
Average Area
In Table 6-15 column 3 shows the ratios of the spectral area (equation 6-1) 
over the average spectral area for each spectral sets and tissue type for each 
patient. The spectral areas are calculated from the raw absorbance spectra in 
figure 6-20 and figure 6-21.__________________________________________






KI = S(X)>f A\ciagc \ru  
Spectral Areo
Normalization was carried out to obtain the same area under the curve for a 
given patient. The Normalization removed undesirable effects such as sample 
thickness
Equation 6-3. (re. page 59) 







Renormalization was carried out to facilitate comparison between (a) 
cancerous to normal colon tissue from the same patient, and (b) inter-patient 
comparison for the same colon tissue types (Le. normal to normal and 
cancerous to cancerous).
The renormalized spectra for patients PA and PB are illustrated in figures 6-23 
and 6-24 respectively for flie same patimh comparison. The raxxmalized




Area to Average 
Area
In Table 6-16 column 4 shows the ratios o f the renormalized spectral area 
(equadon 6-1) over the average renormalized spectral area for all qiectral sets 
for each patient. The spectral areas are calculated from the renormalized 
spectra in figure 6-23 and figure 6-24. In Table 6-18 column 4 shows Ae 
ratios of the renormalized spectral area (equation 6-1) over Ae average 
rox)rmalizedq)ectral area fi)r all spectral sets fix each tissue type. The 
spectral areas are calculated from the renormalized spectra in figure 6-25 and 
figure 6-26.________________________________________________________







Equation 6-4. Same patient Comparison (re. page 62) 
S o e c U " à i D i î k T C P v C =  ! K e n y f ' n 3 l i 4 0 d C  -  R c r - o m j - iL ^ ij d lS ,!
Equation 6-5. Inter-patient Cor iparson ('•e pagr. J7)
terenu' = [Rcnonnahzed? A -  Re ncmahzed^'Bi
The absolute values o f the spectral differences were calculated for the two 
inter-comparisons to investigate variations between spectra.
The errors for the spectral differences are calculated to the standard deviation 
(or root mean square).
-X)'
Where a is the standard deviation, N is number o f data points, X; is a given 
difference and x  is the mean difference.




Table 6-17 summarizes the ratio of the spectral area (Equation 6-1) of the 
spectral difference (Equation 6-4) to the average spectral difference for each 
spectral set for the same patient comparison.
Table 6-19 summarizes the ratio o f the spectral area (Equation 6-1) of the 
spectral difference (Equation 6-5) to the average spectral difference for each 
spectral set for the inter-patient comparison.____________________________
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